Processing 00000000.tx.1: Recruitment of Tumor Necrosis Factor Receptor-associated Factor Family Proteins to Apoptosis Signal-regulating Kinase 1 Signalosome Is Essential for Oxidative Stress-induced Cell Death* Takuya Noguchi, Kohsuke Takeda, Atsushi Matsuzawa, Kaoru Saegusa, Hiroyasu Nakano, Jin Gohda, Jun-ichiro Inoue, and Hidenori Ichijo1 From the Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo, CREST, Japan Science and Technology Corporation, and Strategic Approach to Drug Discovery and Development in Pharmaceutical Sciences, Center of Excellence Program, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan, the Department of Immunology, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan, and the Division of Cellular and Molecular Biology, Department of Cancer Biology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan Received for publication, June 22, 2005 , and in revised form, August 29, 2005.  

Phrase: "Recruitment of Tumor Necrosis Factor Receptor-associated Factor Family Proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C1158950:protein recruitment [Cell Function]
   739   C2949735:Recruitment [Activity]

Phrase: "to Apoptosis Signal-regulating Kinase 1 Signalosome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1167160:signalosome [Cell Component]
   780   C0532128:Apoptosis Signal-Regulating Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
   780   C1417014:APOPTOSIS SIGNAL-REGULATING KINASE 1 [Gene or Genome]

Phrase: "Is"

Phrase: "Essential for Oxidative Stress-induced Cell Death"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205224:Essential [Qualitative Concept]

Phrase: "* Takuya Noguchi,"

Phrase: "Kohsuke Takeda,"

Phrase: "Atsushi Matsuzawa,"

Phrase: "Kaoru Saegusa,"

Phrase: "Hiroyasu Nakano,"

Phrase: "Jin Gohda,"

Phrase: "Jun-ichiro Inoue,"

Phrase: "and"

Phrase: "Hidenori Ichijo1 From the Laboratory of Cell Signaling,"

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "The University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "CREST,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0332243:crest [Functional Concept]
  1000   C1947915:Crest [Spatial Concept]
  1000   C2948667:Crest [Pharmacologic Substance]
   907 E C0229465:cristae [Body Part, Organ, or Organ Component]
   907 E C0230844:cristae [Cell Component]

Phrase: "Japan Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "and"

Phrase: "Strategic Approach to Drug Discovery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449445:Approach [Spatial Concept]

Phrase: "and"

Phrase: "Development in Pharmaceutical Sciences,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243107:development [Physiologic Function]
   770   C0678723:Development [Organism Function]
   770   C1527148:Development [Functional Concept]

Phrase: "Center of Excellence Program,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "7-3-1 Hongo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0720890:hongo [Organic Chemical,Pharmacologic Substance]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 113-0033,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "the Department of Immunology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Juntendo University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "2-1-1 Hongo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0720890:hongo [Organic Chemical,Pharmacologic Substance]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 113-8421,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "and"

Phrase: "the Division of Cellular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Molecular Biology,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "Department of Cancer Biology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1704729:Department [Organization]
   715   C1516164:Biology of Cancer [Biomedical Occupation or Discipline]

Phrase: "The Institute of Medical Science,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "The University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "4-6-1 Shirokanedai,"

Phrase: "Minato-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 108-8639,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "June 22,"

Phrase: "2005 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "August 29,"

Phrase: "2005."
Processing 00000000.tx.2: ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Apoptosis signal-regulating kinase 1 (ASK1) plays a pivotal role in oxidative stress-induced cell death. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Apoptosis signal-regulating kinase 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0532128:Apoptosis Signal-Regulating Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417014:APOPTOSIS SIGNAL-REGULATING KINASE 1 [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0162638:Apoptosis [Cell Function]
   804   C1710082:Signal [Phenomenon or Process]
   733 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: ")"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a pivotal role in oxidative stress-induced cell death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.3: Reactive oxygen species disrupt the interaction of ASK1 with its cellular inhibitor thioredoxin and thereby activates ASK1. 

Phrase: "Reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the interaction of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "with its cellular inhibitor thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "thereby"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.4: However, the precise mechanism by which ASK1 freed from thioredoxin undergoes oligomerization-dependent activation has not been fully elucidated. 

Phrase: "However,"

Phrase: "the precise mechanism by which ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "freed from thioredoxin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   756   C0332296:free [Functional Concept]
   756   C1880497:Free [Qualitative Concept]
   756   C1996904:Free [Qualitative Concept]

Phrase: "undergoes"

Phrase: "oligomerization-dependent activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "fully"

Phrase: "elucidated."
Processing 00000000.tx.5: Here we show that endogenous ASK1 constitutively forms a high molecular mass complex including Trx (1,500-2,000 kDa), which we designate ASK1 signalosome. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that endogenous ASK1 constitutively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1417014:ASK1 [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a high molecular mass complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Trx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(1,500-2,000 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "we"

Phrase: "designate"

Phrase: "ASK1 signalosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1167160:signalosome [Cell Component]
Processing 00000000.tx.6: Upon H2O2 treatment, the ASK1 signalosome forms a higher molecular mass complex at least in part because of the recruitment of tumor necrosis factor receptor-associated factor 2 (TRAF2) and TRAF6. 

Phrase: "Upon H2O2 treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "the ASK1 signalosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1167160:signalosome [Cell Component]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a higher molecular mass complex at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "because of the recruitment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2949735:Recruitment [Activity]

Phrase: "of tumor necrosis factor receptor-associated factor 2"
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   927   C0255813:Tumor Necrosis Factor Receptor 2 [Amino Acid, Peptide, or Protein,Receptor]
   927   C1363982:TUMOR NECROSIS FACTOR RECEPTOR 2 [Gene or Genome]
   927   C1447786:Tumor Necrosis Factor Receptor 2 [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   877   C0077503:Tumor Necrosis Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   845   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   845   C1323304:tumor necrosis factor [Molecular Function]
   845   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C0333516:Tumor necrosis [Neoplastic Process]
   795   C0027540:Necrosis [Organ or Tissue Function]
   795   C0027651:Tumor [Neoplastic Process]
   795   C0332281:Associated [Qualitative Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C1334928:Necrosis [Finding]
   795   C1521761:Factor [Functional Concept]
   795   C1578706:Tumor [Intellectual Product]
   795   C2827422:Factor [Conceptual Entity]
   795   C3273930:Tumor [Finding]
   762 E C0750490:Associate [Idea or Concept]
   762 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: ")"

Phrase: "and"

Phrase: "TRAF6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]
Processing 00000000.tx.7: Consistent with our previous findings that TRAF2 and TRAF6 activate ASK1, H2O2-induced ASK1 activation and cell death were strongly reduced in the cells derived from Traf2-/- and Traf6-/- mice. 

Phrase: "Consistent with our previous findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent
   745   C0332529:Consistency finding [Qualitative Concept]

Phrase: "that TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "H2O2-induced ASK1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "strongly"

Phrase: "reduced in the cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C0392756:Reduced [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "derived from Traf2-/-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0258441:TRAF2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1366777:TRAF2 [Gene or Genome]
   790   C1441547:Derived [Qualitative Concept]
   790   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "Traf6-/- mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.8: A novel signaling complex including TRAF2, TRAF6, and ASK1 may thus be the key component in oxidative stress-induced cell death.  

Phrase: "A novel signaling complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TRAF2,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "TRAF6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "and"

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "may"

Phrase: "thus"

Phrase: "be"

Phrase: "the key component in oxidative stress-induced cell death."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0243092:Cell component [Cell Component]
   762   C1178969:Cell Component [Cell Component]
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.9: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Apoptosis signal-regulating kinase 1 (ASK1)2 is a mitogen-activated protein (MAP) kinase kinase kinase (MAPKKK) family member that activates the JNK and p38 MAP kinase pathways and is activated by various stresses including oxidative stress, TNF, calcium overload, and endoplasmic reticulum stress (1-7). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Apoptosis signal-regulating kinase 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0532128:Apoptosis Signal-Regulating Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417014:APOPTOSIS SIGNAL-REGULATING KINASE 1 [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0162638:Apoptosis [Cell Function]
   804   C1710082:Signal [Phenomenon or Process]
   733 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: ")"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "is"

Phrase: "a mitogen-activated protein (MAP) kinase kinase kinase"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   972   C0211705:Mitogen-Activated Protein Kinase Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   905   C0169101:Mitogen-Activated Protein Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: "(MAPKKK) family member"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0086282:Family member [Family Group]
   901   C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:member [Population Group]
   827   C1704727:Family [Conceptual Entity]
   827   C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "p38 MAP kinase pathways"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   904   C3179232:p38 Kinase Pathways [Cell Function,Molecular Function]
   799   C1704259:Pathways [Molecular Function]
   799   C1705987:Pathways [Conceptual Entity]
   780   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   734   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "is"

Phrase: "activated by various stresses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1879547:Activated [Activity]
   737   C0038435:Stress [Finding]
   737 E C1515877:Activate [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "TNF,"

Phrase: "calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: "overload"

Phrase: ","

Phrase: "and"

Phrase: "endoplasmic reticulum stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "(1-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3541329:1-7 [Gene or Genome]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.10: Recent analyses of ASK1-deficient mice have revealed that ASK1 is required for cell death induced by oxidative stress, TNF, and endoplasmic reticulum stress (4, 8). 

Phrase: "Recent analyses of ASK1-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "is"

Phrase: "required for cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0007587:Cell Death [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0011065:Death [Organism Function]
   770   C1269647:Cell [Cell]
   770   C1306577:Death, NOS [Finding]
   770   C1514873:Required [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "induced by oxidative stress,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0205263:Induced [Functional Concept]
   770   C0311404:Oxidative [Functional Concept]

Phrase: "TNF,"

Phrase: "and"

Phrase: "endoplasmic reticulum stress"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   827   C0038435:Stress [Finding]
   755 E C0231297:Stressful [Functional Concept]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "(4,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.11: Among various stimuli tested, oxidative stress is one of the most potent activators of ASK1 (3). 

Phrase: "Among various stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234402:Stimuli [Phenomenon or Process]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "one of the most potent activators of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205447:One [Quantitative Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.12: Thioredoxin (Trx), a reduction/oxidation (redox) regulatory protein, inhibits the kinase activity of ASK1 by its direct binding to the N-terminal noncatalytic region of ASK1 (6, 9). 

Phrase: "Thioredoxin (Trx),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "a reduction/oxidation (redox) regulatory protein,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0815047:Regulatory Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220905:regulatory [Regulation or Law]
   812   C1704735:Regulatory [Conceptual Entity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the kinase activity of ASK1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150423:kinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "by its direct binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "to the N-terminal noncatalytic region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "(6,"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.13: Reactive oxygen species (ROS) such as H2O2 dissociate Trx from ASK1 and thereby activate ASK1 (6). 

Phrase: "Reactive oxygen species (ROS) such as H2O2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0205332:Reactive [Qualitative Concept]
   753   C1705920:Species [Conceptual Entity]

Phrase: "dissociate"

Phrase: "Trx from ASK1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "thereby"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.14: Following the dissociation of Trx, autophosphorylation-dependent activation of ASK1 occurs most likely through mechanisms involving homo-oligomerization (10, 11); 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the dissociation of Trx,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "autophosphorylation-dependent activation of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "most likely through mechanisms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0750501:most likely [Idea or Concept]
   770   C0332148:Likely [Qualitative Concept]
   770   C0750492:Likely [Idea or Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "homo-oligomerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "(10,"

Phrase: "11"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.15: however, precise mechanisms of the oligomerization-dependent activation of ASK1 remained unknown. 

Phrase: "however,"

Phrase: "precise mechanisms of the oligomerization-dependent activation of ASK1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0441712:Mechanisms [Functional Concept]
   708 E C1706376:Mechanism [Manufactured Object]

Phrase: "remained"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.16: TNF receptor-associated factor 2 (TRAF2) has been shown to bind to and thereby activate ASK1 (5). 

Phrase: "TNF receptor-associated factor 2 (TRAF2)"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "bind to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1145667:Bind [Activity]
   833   C1167622:bind [Molecular Function]

Phrase: "and"

Phrase: "thereby"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.17: TRAF2 is not only a pivotal intermediate in TNF-induced NF-B activation (12-16), but it also activates JNK in TNF signaling through the association with MAPKKKs such as ASK1 and MEKK1 (5, 17, 18). 

Phrase: "TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "a pivotal intermediate in TNF-induced NF-B activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0205103:Intermediate [Spatial Concept]
   742   C1550465:intermediate [Idea or Concept]
   742   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(12-16"

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "it also"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "JNK in TNF signaling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1150587:JNK [Molecular Function]
   770   C1367731:JNK [Gene or Genome]
   770   C1705632:JNK [Gene or Genome]

Phrase: "through the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "with MAPKKKs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0211705:MAPKKKs [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "such as ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "and"

Phrase: "MEKK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150582:MEKK1 [Molecular Function]
  1000   C1367675:MEKK1 [Gene or Genome]
  1000   C1708800:MEKK1 [Gene or Genome]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.18: A recent report has shown that AIP1/DAB2IP, a novel member of Ras-GAP family, regulates TRAF2-dependent activation of ASK1 in TNF-treated endothelial cells (19). 

Phrase: "A recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that AIP1/DAB2IP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424881:DAB2IP [Gene or Genome]

Phrase: "a novel member of Ras-GAP family,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0086282:Family member [Family Group]
   774   C1611821:Family Member [Intellectual Product]
   748   C0680022:member [Population Group]
   748   C2698041:Member [Professional or Occupational Group]

Phrase: "regulates"

Phrase: "TRAF2-dependent activation of ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1514758:Receptor Activation [Cell Function]
   742   C1879547:Activation [Activity]

Phrase: "in TNF-treated endothelial cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0225336:Endothelial Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.19: In accordance with the findings that ROS function as second messengers in TNF signaling (20, 21), TNF-induced association of ASK1 with TRAF2 and subsequent activation of ASK1 have been shown to depend largely on intracellular ROS production by TNF (6, 17). 

Phrase: "In accordance with the findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "that ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "function as second messengers"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0036522:second messengers [Molecular Function]
   833   C1508748:Second Messengers [Biologically Active Substance]
   770   C0031843:function [Physiologic Function]
   770   C0169911:messengers [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0205436:Second [Quantitative Concept]
   770   C0335218:messengers [Professional or Occupational Group]
   770   C0457385:Second [Temporal Concept]
   770   C0542341:Function [Functional Concept]
   770   C0565930:/second [Quantitative Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1561503:second [Idea or Concept]
   770   C1705190:Second [Qualitative Concept]
   770   C1705273:Function [Intellectual Product]

Phrase: "in TNF signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "(20,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "TNF-induced association of ASK1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "with TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "subsequent activation of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "depend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0725813:depend [Medical Device]

Phrase: "largely on intracellular ROS production"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0033268:production [Occupational Activity]
   748   C0175996:intracellular [Cell Component]
   748   C0178719:Intracellular [Spatial Concept]
   748   C0205332:Reactive [Qualitative Concept]
   748   C1705920:Species [Conceptual Entity]

Phrase: "by TNF (6,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.20: In addition to TRAF2, we have previously shown that among extensively characterized six members of the TRAF family (TRAF1-TRAF6) (22-24), TRAF5 and TRAF6 also interact with and activate ASK1 upon overexpression (5). 

Phrase: "In addition to TRAF2,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "we"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that among extensively characterized six members of the TRAF family"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   757   C0086282:Family Members [Family Group]
   741 E C1611821:Family Member [Intellectual Product]
   739   C0015576:Family [Family Group]
   739   C0205452:Six [Quantitative Concept]
   739   C0680022:members [Population Group]
   739   C1704727:Family [Conceptual Entity]
   739   C1880022:Characterized [Activity]
   706 E C2698041:Member [Professional or Occupational Group]

Phrase: "(TRAF1-TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1336666:TRAF6 [Gene or Genome]

Phrase: ")"

Phrase: "(22-24"

Phrase: ")"

Phrase: ","

Phrase: "TRAF5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "and"

Phrase: "TRAF6 also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1336666:TRAF6 [Gene or Genome]

Phrase: "interact with"

Phrase: "and"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1 upon overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1417014:ASK1 [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.21: TRAF5 has been implicated in NF-B and JNK activation in signaling through lymphotoxin- receptor, CD40, and CD27 (25-27). 

Phrase: "TRAF5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in NF-B"

Phrase: "and"

Phrase: "JNK activation in signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "through lymphotoxin- receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "CD40,"

Phrase: "and"

Phrase: "CD27"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538887:CD27 [Gene or Genome]

Phrase: "(25-27"

Phrase: ")."
Processing 00000000.tx.22: Analyses of TRAF5-deficient mice indicated that TRAF5 is required for CD40- and CD27-mediated lymphocyte activation (28). 

Phrase: "Analyses of TRAF5-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that TRAF5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "is"

Phrase: "required for CD40-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Required [Functional Concept]

Phrase: "and"

Phrase: "CD27-mediated lymphocyte activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1267900:CD27+ lymphocyte [Cell]
   861   C0024262:Lymphocyte Activation [Cell Function]
   812   C0024264:Lymphocyte [Cell]
   812   C1879547:Activation [Activity]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.23: TRAF6 is a critical regulator of NF-B and MAP kinases in the signaling pathways through the TNF receptor superfamily and Toll/interleukin-1 receptor family, as has been demonstrated by many studies using TRAF6-deficient mice (29-33). 

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "is"

Phrase: "a critical regulator of NF-B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0182953:REGULATOR [Medical Device]
   753   C1704734:Regulator [Medical Device]
   753   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "MAP kinases in the signaling pathways"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0752312:Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   800   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   770   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   767   C1335962:Signaling Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0026249:Mitogen [Pharmacologic Substance]
   744   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1879547:Activated [Activity]
   711 E C1515877:Activate [Functional Concept]

Phrase: "through the TNF receptor superfamily"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0077503:TNF Receptor Superfamily [Amino Acid, Peptide, or Protein,Receptor]
           TNF Receptor
   827   C1883220:Superfamily [Conceptual Entity]

Phrase: "and"

Phrase: "Toll/interleukin-1 receptor family,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   804   C0015576:Family [Family Group]
   804   C1704727:Family [Conceptual Entity]
   733 E C0241888:Familial [Functional Concept]
   717   C0063710:Interleukin 1 Receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   717   C1416395:INTERLEUKIN 1 RECEPTOR [Gene or Genome]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated by many studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "TRAF6-deficient mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "(29-33"

Phrase: ")."
Processing 00000000.tx.24: Activation of NF-B and MAP kinase pathways by TRAF6 has been reported to be induced through the association with MAPKKKs such as TAK1 and MEKK3 (34, 35). 

Phrase: "Activation of NF-B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "MAP kinase pathways by TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "induced through the association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004083:Association [Mental Process]
   770   C0205263:Induced [Functional Concept]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with MAPKKKs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0211705:MAPKKKs [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "such as TAK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334477:TAK1 [Gene or Genome]
  1000   C1417830:TAK1 [Gene or Genome]
  1000   C1708802:TAK1 [Gene or Genome]

Phrase: "and"

Phrase: "MEKK3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1150582:MEKK3 [Molecular Function]
  1000   C1442513:MEKK3 [Gene or Genome]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.25: In this study, we show that ASK1 constitutively forms a high molecular mass complex (1,500-2,000 kDa). 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that ASK1 constitutively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417014:ASK1 [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a high molecular mass complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(1,500-2,000 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.26: Upon H2O2 treatment, ASK1 was dissociated from Trx but reciprocally associated with TRAF2 and TRAF6. 

Phrase: "Upon H2O2 treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "was"

Phrase: "dissociated from Trx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "but"

Phrase: "reciprocally"

Phrase: "associated with TRAF2"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   897   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   778   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]
Processing 00000000.tx.27: The recruitment of TRAF2 and TRAF6 but not TRAF5 to ASK1 signaling complex was required for H2O2-induced activation of ASK1 and cell death. 

Phrase: "The recruitment of TRAF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C2949735:Recruitment [Activity]
   703   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "but"

Phrase: "not TRAF5 to ASK1 signaling complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1420889:TRAF5 [Gene or Genome]

Phrase: "was"

Phrase: "required for H2O2-induced activation of ASK1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C1417014:ASK1 [Gene or Genome]
   748   C1514873:Required [Functional Concept]
   748   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.28: These results propose a novel signaling mechanism involving TRAF family proteins and ASK1 in oxidative stress-induced cell death.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "propose"

Phrase: "a novel signaling mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "TRAF family proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1449799:TRAF Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "ASK1 in oxidative stress-induced cell death."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.29: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Cell Culture and PlasmidsHEK293 cells and mouse embryonic fibroblasts (MEFs) were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 4.5 g/liter glucose, and 100 units/ml penicillin G in a 5% CO2 atmosphere at 37 C. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Cell Culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "PlasmidsHEK293 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "mouse embryonic fibroblasts (MEFs)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1516828:Mouse Embryonic Fibroblast [Tissue]
   896   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "cultured in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   767   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "4.5 g/liter glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "100 units/ml penicillin G in a 5% CO2 atmosphere"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030827:Penicillin G [Antibiotic,Organic Chemical]
   757   C1300565:g/mL [Quantitative Concept]
   757   C1637390:mL/g [Quantitative Concept]
   739   C0030842:Penicillin [Antibiotic,Organic Chemical]
   739   C0220892:Penicillin [Antibiotic,Organic Chemical]
   739   C0439267:g% [Quantitative Concept]

Phrase: "at 37 C."
Processing 00000000.tx.30: HA-tagged wild-type ASK1 (ASK1WT-HA) and HA-tagged C-terminal coiled-coil domain deletion mutant of ASK1 (ASK1coil-HA) have been described previously (11). 

Phrase: "HA-tagged wild-type ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417014:ASK1 [Gene or Genome]

Phrase: "(ASK1WT-HA)"

Phrase: "and"

Phrase: "HA-tagged C-terminal coiled-coil domain deletion mutant of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(ASK1coil-HA)"

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.31: Reagents and AntibodiesTransfection was performed with FuGENE 6 (Roche Applied Science) according to the manufacturer's instructions. 

Phrase: "Reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "AntibodiesTransfection"

Phrase: "was"

Phrase: "performed with FuGENE 6"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0916399:FuGene 6 [Lipid]
           FuGene
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Roche Applied Science"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   901   C0681834:Applied Science [Research Activity]
   827   C0036397:Science [Occupation or Discipline]
   827   C0185125:Applied [Health Care Activity]
   793 E C1632850:Apply [Functional Concept]
   793 E C1879355:Apply [Functional Concept]

Phrase: ")"

Phrase: "according to the manufacturer's instructions."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302828:instructions [Intellectual Product]
   861   C1442085:Instructions [Idea or Concept]
   861   C3263700:Instructions [Clinical Attribute]
   827 E C0039401:Instruction [Educational Activity]
Processing 00000000.tx.32: Human recombinant TNF was obtained from WAKO. 

Phrase: "Human recombinant TNF"

Phrase: "was"

Phrase: "obtained from WAKO."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.33: The antibody to HA (clone 3F10) was from Roche Applied Science. 

Phrase: "The antibody to HA (clone 3F10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: ")"

Phrase: "was from Roche Applied Science."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0681834:Applied Science [Research Activity]
   760   C0036397:Science [Occupation or Discipline]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0185125:Applied [Health Care Activity]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0331965:Roche [Health Care Related Organization]
   760   C1421478:WAS [Gene or Genome]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.34: Phospho-JNK (Thr183/Tyr185) and phospho-p38 (Thr180/Tyr182) antibodies were from Cell Signaling Technology. 

Phrase: "Phospho-JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1150587:JNK [Molecular Function]
   861   C1367731:JNK [Gene or Genome]
   861   C1705632:JNK [Gene or Genome]

Phrase: "(Thr183/Tyr185"

Phrase: ")"

Phrase: "and"

Phrase: "phospho-p38"

Phrase: "(Thr180/Tyr182"

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Cell Signaling Technology."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0037083:Cell Signaling [Cell Function]
           Signaling
   760   C0007634:Cell [Cell]
   760   C0039421:Technology [Occupation or Discipline]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3537152:signaling [Biologic Function]
   726 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.35: Anti-ASK1, anti-Trx, anti-TRAF2, anti-TRAF5, and anti-TRAF6 antibodies were from Santa Cruz Biotechnology, Inc. 

Phrase: "Anti-ASK1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417014:ASK1 [Gene or Genome]

Phrase: "anti-Trx,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "anti-TRAF2,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   947   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   827   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0332281:Associated [Qualitative Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   766 E C0750490:Associate [Idea or Concept]
   766 E C1706221:Associate [Professional or Occupational Group]

Phrase: "anti-TRAF5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420889:TRAF5 [Gene or Genome]

Phrase: "and"

Phrase: "anti-TRAF6 antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were from Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Inc."
Processing 00000000.tx.36: Affinity-purified rabbit polyclonal antibody raised against phospho-ASK1 (Thr838) was described previously (11). 

Phrase: "Affinity-purified rabbit polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised against phospho-ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442818:Raised [Quantitative Concept]
   770   C1417014:ASK1 [Gene or Genome]

Phrase: "(Thr838"

Phrase: ")"

Phrase: "was"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.37: To generate anti-TRAF6 antibody, the synthetic peptide RKEGFQPRSTD was used as immunogen, and the antisera obtained from immunized rabbit was affinity-purified by the synthetic peptide (36). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "anti-TRAF6 antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "the synthetic peptide RKEGFQPRSTD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "used as immunogen,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0003320:Immunogen [Immunologic Factor]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
   718 E C0872192:immunogenic [Functional Concept]

Phrase: "and"

Phrase: "the antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "obtained from immunized rabbit"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0034493:Rabbit [Mammal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "was"

Phrase: "affinity-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "purified by the synthetic peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C1883254:synthetic [Activity]
   760   C1998793:Purified [Functional Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.38: Preparation of S-100 FractionTo purify the ASK1 complex, HEK293 cells were stimulated with 0.5 mM H2O2 or 100 ng/ml TNF. 

Phrase: "Preparation of S-100 FractionTo"

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "the ASK1 complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stimulated with 0.5 mM H2O2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "100 ng/ml TNF."
Processing 00000000.tx.39: The cells (5 x 107 cells/ml) were washed twice with ice-cold phosphate-buffered saline and were lysed by using a glass Dounce homogenizer in buffer A (50 mM HEPES-KOH, pH 7.5, 10 mM KCl, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1.5 mM MgCl2, and 10% glycerol) plus 0.1% Chaps and 0.01% Brij35, supplemented with 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 5 g/ml aprotinin. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(5 x 107 cells/ml)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C2699156:Cells/mL [Quantitative Concept]
   804   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice with ice-cold phosphate-buffered saline"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0456963:Ice cold [Qualitative Concept]
   774   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0031701:phosphate [Organophosphorus Compound]
   748   C0036082:Saline [Substance]
   748   C0234192:Cold [Physiologic Function]
   748   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   748   C1720725:Twice [Intellectual Product]
   748   C1948050:Twice [Quantitative Concept]

Phrase: "and"

Phrase: "were"

Phrase: "lysed by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0024348:lysed [Pathologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a glass Dounce homogenizer in buffer A (50 mM HEPES-KOH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0181200:homogenizer [Medical Device]

Phrase: "pH 7.5,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "10 mM KCl,"

Phrase: "150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1.5 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "10% glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "plus 0.1% Chaps"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   779 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "0.01% Brij35,"

Phrase: "supplemented with 1 mM dithiothreitol,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1418486:MM-1 [Gene or Genome]
   760   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5 g/ml aprotinin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.40: The homogenate was centrifuged at 10,000 x g for 30 min at 4 C. 

Phrase: "The homogenate"

Phrase: "was"

Phrase: "centrifuged at 10,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.41: The supernatant was recentrifuged at 105,000 x g for 90 min at 4 C. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "recentrifuged at 105,000 x g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439267:g% [Quantitative Concept]

Phrase: "for 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4 C."
Processing 00000000.tx.42: The supernatant (S-100) was flash-frozen and stored at -135 C. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "(S-100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441165:S-100 [Immunologic Factor]
   861   C2603362:S' [Clinical Attribute]

Phrase: ")"

Phrase: "was"

Phrase: "flash-frozen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882516:Flash Frozen [Laboratory Procedure]
   861   C0016701:Frozen [Natural Phenomenon or Process]
   861   C0677542:Frozen [Functional Concept]

Phrase: "and"

Phrase: "stored"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1698986:Store [Functional Concept]

Phrase: "at -135 C."
Processing 00000000.tx.43: Gel Filtration ChromatographyS-100 fraction from HEK293 cells was loaded onto a Superose6 10/300 GL column pre-equilibrated with buffer A plus 0.1% Chaps and 0.01% Brij35. 

Phrase: "Gel Filtration ChromatographyS-100 fraction from HEK293 cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   750   C0805525:Cell Fraction [Cell Component]
   744   C1264633:Fraction [Quantitative Concept]
   744   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "loaded onto a Superose6 10/300 GL column"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   744   C0018229:GL [Geographic Area]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1423073:GL [Gene or Genome]
   744   C1427674:GL [Gene or Genome]
   744   C1706132:Column [Idea or Concept]
   744   C1708715:Loaded [Activity]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]

Phrase: "pre-equilibrated with buffer A plus 0.1% Chaps"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   742   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   742   C0332152:Pre [Temporal Concept]
   742   C0332287:Plus [Qualitative Concept]
   742   C0740175:Pre [Qualitative Concept]
   742   C2257086:PRE [Genetic Function]
   708 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "0.01% Brij35."
Processing 00000000.tx.44: The proteins were eluted at 0.3 ml/min. 

Phrase: "The proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "eluted at 0.3 ml/min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439445:mL/min [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C0702093:/min [Temporal Concept]
Processing 00000000.tx.45: Each fraction (0.5 ml/fraction) was precipitated using acetone/ethanol (1:4). 

Phrase: "Each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "(0.5 ml/fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "precipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "acetone/ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2928658:Acetone / Ethanol [Pharmacologic Substance]
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.46: Samples from one or four column runs were pooled and analyzed by Western blotting for the indicated antibodies. 

Phrase: "Samples from one"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0370003:Sample [Substance]
   756   C2347026:Sample [Conceptual Entity]

Phrase: "or"

Phrase: "four column runs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0600140:Runs [Finding]
   793 E C0035953:run [Daily or Recreational Activity]
   793 E C1704688:Run [Functional Concept]
   793 E C2346414:Run [Finding]

Phrase: "were"

Phrase: "pooled"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1709595:Pooled [Conceptual Entity]
  1000   C2349200:Pooled [Functional Concept]
   966 E C0337051:Pool [Geographic Area]
   966 E C1509144:pool [Clinical Attribute]

Phrase: "and"

Phrase: "analyzed by Western blotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0005863:Western Blotting [Laboratory Procedure,Molecular Biology Research Technique]
   816 E C0949466:Western Blot [Laboratory Procedure]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "for the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.47: ImmunoblottingThe cells were lysed in buffer A plus 0.2% Nonidet P-40, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 5 g/ml aprotinin. 

Phrase: "ImmunoblottingThe cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in buffer A plus 0.2% Nonidet P-40,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0024348:lysed [Pathologic Function]
   739   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   739   C0332287:Plus [Qualitative Concept]
   739   C0439509:/40 [Temporal Concept]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5 g/ml aprotinin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.48: The cell extracts were resolved by SDS-PAGE and transferred to polyvinylidene difluoride membranes. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "transferred to polyvinylidene difluoride membranes."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0071710:polyvinylidene difluoride [Organic Chemical]
   760   C0025255:Membranes [Tissue]
   760   C0348011:transferred [Functional Concept]
   726 E C0040671:Transfer [Mental Process]
   726 E C0596901:Membrane [Cell Component]
   726 E C1705822:Transfer [Activity]
   726 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.49: After blocking with 5% skim milk in TBS-T (150 mM NaCl, 50 mM Tris-HCl, pH 8.0, and 0.05% Tween 20), the membranes were probed with the indicated antibodies. 

Phrase: "After"

Phrase: "blocking with 5% skim milk"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   806   C0349375:Skim milk [Food]
   760   C0026131:Milk [Body Substance]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   760   C0349374:Milk [Food]
   760   C0444318:Milk [Substance]
   760   C2825079:Milk [Food]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1706084:Block [Geographic Area]
   726 E C2828370:Block [Quantitative Concept]
   704 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   704 E C1281353:Lacteal [Body Part, Organ, or Organ Component]

Phrase: "in TBS-T (150 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C1959973:% NaCl [Quantitative Concept]

Phrase: "50 mM Tris-HCl,"

Phrase: "pH 8.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "0.05% Tween 20"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "the membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "probed with the indicated antibodies."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C1444656:Indicated [Finding]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   726   C0182400:Probe [Medical Device]
   726   C1704681:Probe [Gene or Genome]
   726   C2347609:Probe [Chemical Viewed Functionally]
   726   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.50: The antibody-antigen complexes were detected using the ECL system (Amersham Biosciences). 

Phrase: "The antibody-antigen complexes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]
   734   C0368675:antibody antigen [Immunologic Factor]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ECL system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")."
Processing 00000000.tx.51: Co-immunoprecipitation AnalysisThe cells were lysed in buffer A plus 0.2% Nonidet P-40, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, and 5 g/ml aprotinin. 

Phrase: "Co-immunoprecipitation AnalysisThe cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed in buffer A plus 0.2% Nonidet P-40,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   782   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   739   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   739   C0024348:lysed [Pathologic Function]
   739   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   739   C0332287:Plus [Qualitative Concept]
   739   C0439509:/40 [Temporal Concept]

Phrase: "1 mM dithiothreitol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "1 mM phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   812   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "5 g/ml aprotinin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.52: The cell extracts were immunoprecipitated with 20 l of protein A- or protein G-Sepharose beads (Amersham Biosciences) for overnight at 4 C with the indicated antibodies. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoprecipitated with 20 l of protein A-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "protein G-Sepharose beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0991566:Beads [Biomedical or Dental Material]
   779 E C2346972:Bead [Spatial Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "for overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "at 4 C"

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.53: The beads were washed four times with the same buffer before analysis by SDS-PAGE. 

Phrase: "The beads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0991566:Beads [Biomedical or Dental Material]
   966 E C2346972:Bead [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "four times with the same buffer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0040223:times [Temporal Concept]
   753   C1632851:Times [Quantitative Concept]
   719 E C3541383:Time [Temporal Concept]

Phrase: "before analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "by SDS-PAGE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]
Processing 00000000.tx.54: Preparation of Splenocyte-derived MacrophageBecause the number of bone marrow cells was reduced significantly in Traf6-/- mice because of severe osteopetrosis, macrophages were generated from splenocytes of Traf6+/- and Traf6-/- mice (30). 

Phrase: "Preparation of Splenocyte-derived MacrophageBecause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]

Phrase: "the number of bone marrow cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "significantly in Traf6-/- mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1336666:TRAF6 [Gene or Genome]

Phrase: "because of severe osteopetrosis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1318518:Severe osteopetrosis [Congenital Abnormality,Disease or Syndrome]
   861   C0029454:Osteopetrosis [Congenital Abnormality,Disease or Syndrome]

Phrase: "macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "were"

Phrase: "generated from splenocytes of Traf6+/-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1336666:TRAF6 [Gene or Genome]
   760   C3146294:Generated [Activity]
   726   C1519477:Splenocyte [Cell]

Phrase: "and"

Phrase: "Traf6-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.55: After 6 days of culture with macrophage colony-stimulating factor (M-CSF), almost equal numbers of adherent cells, which displayed typical macrophage morphology, were obtained from both Traf6+/- and Traf6-/- splenocytes. 

Phrase: "After 6 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442469:6 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "of culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "with macrophage colony-stimulating factor (M-CSF),"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
  1000   C0079784:Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524095:macrophage colony-stimulating factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   923   C0079460:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0024432:macrophage [Cell]
   812   C0439158:colony [Quantitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1947989:Colony [Cell]
   812   C1948023:Stimulating [Natural Phenomenon or Process]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "almost equal numbers of adherent cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "which"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "typical macrophage morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "were"

Phrase: "obtained from both Traf6+/-"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1301820:Obtained [Functional Concept]
   770   C1336666:TRAF6 [Gene or Genome]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "Traf6-/- splenocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1519477:Splenocyte [Cell]
Processing 00000000.tx.56: More than 95% of the adherent cells from both Traf6+/- and Traf6-/- mice expressed CD11b and F4/80 (data not shown), indicating that TRAF6 deficiency does not affect macrophage differentiation. 

Phrase: "More than 95% of the adherent cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0007634:Cells [Cell]
   748   C0205172:More [Functional Concept]
   748   C0334154:Adherent [Functional Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "from both Traf6+/-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "and"

Phrase: "Traf6-/- mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "expressed"

Phrase: "CD11b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541224:CD11B [Laboratory Procedure]

Phrase: "and"

Phrase: "F4/80"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that TRAF6 deficiency"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0011155:Deficiency [Functional Concept]
   861   C0162429:Deficiency [Disease or Syndrome]
   861   C1623416:deficiency [Qualitative Concept]
   789 E C1636779:% deficient [Quantitative Concept]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "macrophage differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C1159946:macrophage differentiation [Cell Function]
   861   C0007589:Differentiation [Cell Function]
   861   C1511938:Differentiation [Clinical Attribute]
   861   C2945687:Differentiation [Functional Concept]
   789 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.57: Trypan Blue Dye Exclusion AssayFor the trypan blue dye exclusion assay, cells (1 x 104 cells/well) were plated in 12-well plates. 

Phrase: "Trypan Blue Dye Exclusion AssayFor"

Phrase: "the trypan blue dye exclusion assay,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   804   C0243073:assay [Qualitative Concept]
   804   C0680251:EXCLUSION [Functional Concept]
   804   C1510438:Assay [Laboratory Procedure]
   804   C2828389:Exclusion [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(1 x 104 cells/well"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   840   C2347578:Cells/well [Quantitative Concept]
   804   C0007634:Cells [Cell]
   804   C0205170:Well [Qualitative Concept]
   804   C2827734:1+ [Quantitative Concept]
   804   C2981698:1+ [Classification]
   804   C3146287:Well [Manufactured Object]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "plated in 12-well plates."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205170:Well [Qualitative Concept]
   760   C1139930:plates [Medical Device]
           plate
   760   C3146287:Well [Manufactured Object]
   726   C0005971:Plate [Medical Device]
   726   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.58: Twenty-four h after the plating, the cells were treated with 0.1 mM H2O2 for 10 h. 

Phrase: "Twenty-four h after the plating,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0.1 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 10 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.59: The cells were then directly stained with 0.4% trypan blue dye or harvested with trypsin followed by staining with 0.4% trypan blue dye. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883708:Then [Temporal Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "stained with 0.4% trypan blue dye"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   788   C0041213:Trypan blue stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Trypan Blue
   748   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   748   C1260957:Blue [Qualitative Concept]
   748   C1565627:Trypan [Organic Chemical]
   748   C2986582:Stained [Qualitative Concept]
   714 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "or"

Phrase: "harvested with trypsin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   756   C1512335:Harvest [Health Care Activity]

Phrase: "followed by staining"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with 0.4% trypan blue dye."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.60: The trypan blue-positive cells were counted by using a hemocytometer under phase contrast microscopy.  

Phrase: "The trypan blue-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0439178:% positive cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0750480:Count [Activity]
   799   C1705566:Count [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a hemocytometer under phase contrast microscopy."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0181168:HEMOCYTOMETER [Medical Device]
Processing 00000000.tx.61: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  ASK1 Forms a High Molecular Mass Signaling Complex in the CellWe previously demonstrated that phosphorylation of a threonine residue within the activation loop of ASK1 kinase domain (Thr838 and Thr845 of human and mouse ASK1, respectively) is required for activation of ASK1 in response to various stresses (11). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "Forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a High Molecular Mass Signaling Complex in the CellWe previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0439855:Complex [Qualitative Concept]
   739   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "demonstrated"

Phrase: "that phosphorylation of a threonine residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "within the activation loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0419518:Loop [Medical Device]
   861   C0445022:Loop [Spatial Concept]

Phrase: "of ASK1 kinase domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "(Thr838"

Phrase: "and"

Phrase: "Thr845 of human"

Phrase: "and"

Phrase: "mouse ASK1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417014:ASK1 [Gene or Genome]

Phrase: "respectively"

Phrase: ")"

Phrase: "is"

Phrase: "required for activation of ASK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1417014:ASK1 [Gene or Genome]
   760   C1514873:Required [Functional Concept]
   760   C1879547:Activation [Activity]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to various stresses"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0038435:Stress [Finding]
   777 E C0231297:Stressful [Functional Concept]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.62: We also showed that the activation state of ASK1 can be monitored by the phospho-ASK1 antibody that detects activating phosphorylation of this threonine residue (11). 

Phrase: "We also"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the activation state of ASK1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1879547:Activation [Activity]
   760   C3148680:State [Geographic Area]

Phrase: "can"

Phrase: "be"

Phrase: "monitored by the phospho-ASK1 antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1417014:ASK1 [Gene or Genome]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719   C1521743:Monitor [Professional or Occupational Group]
   719   C1704646:Monitor [Manufactured Object]

Phrase: "that"

Phrase: "detects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "activating phosphorylation of this threonine residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.63: Immunoblotting analysis using the phospho-ASK1 antibody revealed that basal activity of a mutant form of ASK1 that lacked C-terminal coiled-coil domain (ASK1coil) was much lower than that of wild-type ASK1 (ASK1WT) when each construct was expressed in HEK293 cells (Fig. 1, A and B). 

Phrase: "Immunoblotting analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0020985:Immunoblot Analysis [Laboratory Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the phospho-ASK1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that basal activity of a mutant form of ASK1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "that lacked C-terminal coiled-coil domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1516692:Coiled-Coil Domain [Amino Acid Sequence]
   799   C1880389:Domain [Functional Concept]
   799   C1883221:Domain [Conceptual Entity]
   799   C3541951:Domain [Intellectual Product]

Phrase: "(ASK1coil"

Phrase: ")"

Phrase: "was"

Phrase: "much lower than that of wild-type ASK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0441994:Lower [Spatial Concept]
   744   C1548802:Lower [Body Location or Region]
   744   C2003888:Lower [Activity]

Phrase: "(ASK1WT"

Phrase: ")"

Phrase: "when"

Phrase: "each construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "expressed in HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.64: Overexpression of ASK1coil was not able to induce the activation of JNK and p38 nor to inhibit the activity of co-transfected ASK1WT (data not shown). 

Phrase: "Overexpression of ASK1coil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514559:Overexpression [Genetic Function]

Phrase: "was"

Phrase: "not able to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085732:Able [Organism Attribute]
   827   C1299581:Able [Finding]
   827   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the activation of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "p38"

Phrase: "nor"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the activity of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0205177:Activity [Functional Concept]
   790   C0439167:% activity [Quantitative Concept]
   790   C0441655:Activity [Activity]
   790   C1561536:*Activity [Idea or Concept]

Phrase: "co-transfected"

Phrase: "ASK1WT"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.65: These results confirm our previous finding that homo-oligomerization through the C-terminal coiled-coil domain is required for the activation of ASK1 (11); 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "our previous finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037088:Finding [Sign or Symptom]
   861   C0243095:Finding [Finding]
   861   C2825141:Finding [Finding]

Phrase: "that homo-oligomerization through the C-terminal coiled-coil domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1300203:Homo [Mammal]
   739   C3245470:HOMO [Finding]

Phrase: "is"

Phrase: "required for the activation of ASK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1417014:ASK1 [Gene or Genome]
   753   C1514873:Required [Functional Concept]
   753   C1879547:Activation [Activity]

Phrase: "(11"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.66: however, regulatory mechanisms of ASK1 oligomer have been largely unknown. 

Phrase: "however,"

Phrase: "regulatory mechanisms of ASK1 oligomer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "have"

Phrase: "been"

Phrase: "largely unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.67: To investigate how homo-oligomerization of ASK1 is involved in its activation, we first examined the potential complex formation of ASK1 in the cells using a gel filtration column chromatography by an approach similar to that used to characterize the apoptosome (37). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "how homo-oligomerization of ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1300203:Homo [Mammal]
   760   C3245470:HOMO [Finding]

Phrase: "is"

Phrase: "involved in its activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1314939:Involved [Functional Concept]
   770   C1879547:Activation [Activity]

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the potential complex formation of ASK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "in the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a gel filtration column chromatography by an approach"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0008559:Gel Filtration Chromatography [Laboratory Procedure]
           Gel Chromatography
   770   C0684296:Column Chromatography [Laboratory Procedure]
   744   C0008550:Chromatography [Laboratory Procedure]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1706132:Column [Idea or Concept]

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "characterize"

Phrase: "the apoptosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1657248:Apoptosome [Cell Component]

Phrase: "(37"

Phrase: ")."
Processing 00000000.tx.68: The expected molecular mass of monomeric ASK1 is 160 kDa. 

Phrase: "The expected molecular mass of monomeric ASK1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]

Phrase: "is"

Phrase: "160 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.69: When HA-tagged ASK1WT was expressed in HEK293 cells, we found that ASK1WT formed a high molecular mass (HMM) complex in fractions 1-8 (>1,500 kDa; Fig. 1C, top panel, lanes 1-8) with relatively high basal activity detected by the phospho-ASK1 antibody (Fig. 1C, second panel). 

Phrase: "When"

Phrase: "HA-tagged ASK1WT"

Phrase: "was"

Phrase: "expressed in HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that ASK1WT"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a high molecular mass (HMM) complex in fractions 1-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "("

Phrase: ">1,500 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "; Fig. 1C,"

Phrase: "top panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 1-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "with relatively high basal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "detected by the phospho-ASK1 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0442726:Detected [Finding]
   753   C1417014:ASK1 [Gene or Genome]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 1C,"

Phrase: "second panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.70: A kinase-negative mutant of ASK1 (ASK1K709R) also formed an HMM complex (data not shown), suggesting that the kinase activity of ASK1 is not a prerequisite for the HMM complex formation. 

Phrase: "A kinase-negative mutant of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(ASK1K709R"

Phrase: ")"

Phrase: "also"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "an HMM complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the kinase activity of ASK1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150423:kinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "a prerequisite for the HMM complex formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0679209:prerequisite [Idea or Concept]
Processing 00000000.tx.71: On the other hand, ASK1coil formed a smaller complex (500 kDa; but still larger than monomeric ASK1) with no detectable activity (Fig. 1C, bottom two panels, lanes 11-15). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "ASK1coil"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a smaller complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(500 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ";"

Phrase: "but"

Phrase: "still larger than monomeric ASK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0443228:larger [Quantitative Concept]
   760   C0549177:Larger [Quantitative Concept]
   760   C1704243:Larger [Quantitative Concept]

Phrase: ")"

Phrase: "with no detectable activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 1C,"

Phrase: "bottom two panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "lanes 11-15"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.72: It is noteworthy that a minor part of transfected ASK1coil also formed an HMM complex with certain kinase activity (Fig. 1C, bottom two panels, lanes 5-7). 

Phrase: "It"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that"

Phrase: "a minor part of transfected ASK1coil also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "an HMM complex with certain kinase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Fig. 1C,"

Phrase: "bottom two panels,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "lanes 5-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.73: These results suggest that oligomerization-dependent formation of the HMM complex is required for the kinase activity of ASK1. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that oligomerization-dependent formation of the HMM complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "required for the kinase activity of ASK1."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1150423:kinase activity [Molecular Function]
   748   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1417014:ASK1 [Gene or Genome]
   748   C1514873:Required [Functional Concept]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.74: ROS Induce a Higher Molecular Mass Complex Formation of ASK1We next examined the states of endogenous ASK1 by gel filtration analysis. 

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "Induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a Higher Molecular Mass Complex Formation of ASK1We next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the states of endogenous ASK1"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1301808:states [Geographic Area]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "by gel filtration analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0008559:Gel Filtration [Laboratory Procedure]
Processing 00000000.tx.75: Fractionation of the extracts from HEK293 cells through a gel filtration column revealed that although confined to fractions 5-8 (1,500-2,000 kDa), endogenous ASK1 formed a similar HMM complex as was formed by exogenously expressed ASK1WT (Fig. 2A, top panel). 

Phrase: "Fractionation of the extracts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016640:fractionation [Laboratory Procedure]
   770   C0524811:fractionation [Therapeutic or Preventive Procedure]
   770   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "from HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "through a gel filtration column"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]
   734   C0008559:Gel Filtration [Laboratory Procedure]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "although"

Phrase: "confined to fractions 5-8"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1264633:Fractions [Quantitative Concept]
   726 E C1554103:Fraction [Idea or Concept]

Phrase: "(1,500-2,000 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "endogenous ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417014:ASK1 [Gene or Genome]

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "a similar HMM complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "as"

Phrase: "was"

Phrase: "formed by exogenously expressed ASK1WT"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0205431:Formed [Functional Concept]
   726 E C0348078:Form [Qualitative Concept]
   726 E C0376315:Form [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "(Fig. 2A,"

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.76: A similar pattern of HMM complex was detected in all of the cultured cells we tested, e.g. 

Phrase: "A similar pattern of HMM complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "detected in all of the cultured cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   778   C0007600:cultured cells [Cell]
   778   C0007635:Cultured Cells [Cell]
   778   C3282338:Cells, Cultured [Cell]
   757 E C0007585:cells culture [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C3282337:Cells [Cell]
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
   714   C2242979:Culture [Laboratory Procedure]

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: ","

Phrase: "e.g."
Processing 00000000.tx.77: HeLa cells, HT1080 cells, and MEFs (data not shown), suggesting that the HMM complex formation is a general feature of endogenous ASK1. 

Phrase: "HeLa cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0018873:HeLa Cells [Cell]
           HeLa
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "HT1080 cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1516828:Mouse Embryonic Fibroblast [Tissue]
   896   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the HMM complex formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "a general feature of endogenous ASK1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]
Processing 00000000.tx.78: Under unstimulated conditions, the kinase activity of ASK1 is negatively regulated by its association with Trx (6). 

Phrase: "Under unstimulated conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the kinase activity of ASK1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1150423:kinase activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "is"

Phrase: "negatively"

Phrase: "regulated by its association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "with Trx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.79: To examine whether Trx is a component of the unstimulated HMM complex, ASK1-containing fractions (corresponding to lanes 5-8 in Fig. 2A, top panel) were collected and subjected to immunoprecipitation with anti-ASK1 antibody. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "Trx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "is"

Phrase: "a component of the unstimulated HMM complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]

Phrase: "ASK1-containing fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "("

Phrase: "corresponding to lanes 5-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1708639:Lane [Spatial Concept]

Phrase: "in Fig. 2A,"

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "subjected to immunoprecipitation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-ASK1 antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.80: Trx was found to be co-immunoprecipitated with ASK1 (Fig. 2B), indicating that endogenous ASK1 forms a static HMM complex containing Trx, which may function as a signalosome competent to ROS-dependent activation of ASK1. 

Phrase: "Trx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "co-immunoprecipitated with ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1417014:ASK1 [Gene or Genome]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that endogenous ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417014:ASK1 [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a static HMM complex containing Trx,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   795   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "which"

Phrase: "may"

Phrase: "function as a signalosome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1167160:signalosome [Cell Component]
   770   C1705273:Function [Intellectual Product]

Phrase: "competent to ROS-dependent activation of ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0086035:Competent [Qualitative Concept]
Processing 00000000.tx.81: View larger version (25K): [in this window] [in a new window]  FIGURE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 1."
Processing 00000000.tx.82: ASK1 forms a high molecular mass signaling complex in the cell. 

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a high molecular mass signaling complex in the cell."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.83: A, schematic illustrations of human ASK1WT and ASK1coil with amino acid numbers. 

Phrase: "A,"

Phrase: "schematic illustrations of human ASK1WT"

Phrase: "and"

Phrase: "ASK1coil with amino acid numbers."
Processing 00000000.tx.84: B, requirement of C-terminal coiled-coil domain of ASK1 for its basal kinase activity. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "requirement of C-terminal coiled-coil domain of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1514873:Requirement [Functional Concept]

Phrase: "for its basal kinase activity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150423:kinase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.85: HEK293 cells were transiently transfected with HA-tagged wild-type ASK1 expression plasmid (ASK1WT-HA), C-terminal coiled-coil domain deletion mutant (ASK1coil-HA), or control vector (pcDNA3). 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with HA-tagged wild-type ASK1 expression plasmid"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   764   C1883559:Wild Type [Organism Attribute]
   742   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0332307:Type [Qualitative Concept]
   742   C0445392:Wild [Intellectual Product]
   742   C1417014:ASK1 [Gene or Genome]
   742   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   742   C1547052:*Type [Quantitative Concept]
   742   C1708632:Tagged [Qualitative Concept]
   708 E C0037293:Tag [Neoplastic Process]
   708 E C0181496:Tag [Manufactured Object]
   708 E C1710492:TAG [Gene or Genome]

Phrase: "(ASK1WT-HA"

Phrase: ")"

Phrase: ","

Phrase: "C-terminal coiled-coil domain deletion mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(ASK1coil-HA"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "control vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031249:control vector [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "(pcDNA3"

Phrase: ")."
Processing 00000000.tx.86: After 36 h, the cell extracts were subjected to immunoblotting with anti-HA antibody (3F10) and phospho-specific ASK1 antibody (p-ASK). 

Phrase: "After 36 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-HA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(3F10"

Phrase: ")"

Phrase: "and"

Phrase: "phospho-specific ASK1 antibody (p-ASK)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.87: C, gel filtration analysis of ASK1WT and ASK1coil mutant. 

Phrase: "C,"

Phrase: "gel filtration analysis of ASK1WT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "ASK1coil mutant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]
Processing 00000000.tx.88: HEK293 cells were transiently transfected with ASK1WT-HA or ASK1coil-HA in a 100-mm-diameter dish. 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with ASK1WT-HA"

Phrase: "or"

Phrase: "ASK1coil-HA in a 100-mm-diameter dish."
Processing 00000000.tx.89: After 36 h, the cell extracts were prepared as described under "Materials and Methods" and fractionated through a Superose6 10/300 GL column. 

Phrase: "After 36 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "fractionated through a Superose6 10/300 GL column."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0018229:GL [Geographic Area]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1423073:GL [Gene or Genome]
   744   C1427674:GL [Gene or Genome]
   744   C1706132:Column [Idea or Concept]
   744   C1979893:Fractionated [Qualitative Concept]
Processing 00000000.tx.90: Each fraction (50 l) was analyzed by immunoblotting with the indicated antibodies. 

Phrase: "Each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "(50 l)"

Phrase: "was"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.91: Apparent molecular mass was evaluated after column calibration with standard proteins: thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), and aldolase (158 kDa). 

Phrase: "Apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "was"

Phrase: "evaluated after column calibration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006751:Calibration [Quantitative Concept]
   770   C0220825:Evaluated [Functional Concept]
   770   C1185738:Column [Body Part, Organ, or Organ Component]
   770   C1706132:Column [Idea or Concept]

Phrase: "with standard proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "thyroglobulin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0040123:Thyroglobulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1527123:Thyroglobulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   944 E C3642448:Proloid [Pharmacologic Substance]

Phrase: "(669 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "ferritin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015879:Ferritin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(440 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "catalase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007367:CATALASE [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1413138:CATALASE [Gene or Genome]

Phrase: "(232 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "aldolase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016762:Aldolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(158 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.92: The elution positions of these proteins are indicated at the top of the figure. 

Phrase: "The elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "positions of these proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0733755:Position [Spatial Concept]

Phrase: "are"

Phrase: "indicated at the top of the figure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1444656:Indicated [Finding]
   748   C1704458:Top [Spatial Concept]
Processing 00000000.tx.93: WB, Western blot; 

Phrase: "WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:Wb [Quantitative Concept]

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.94: WT, wild type.  

Phrase: "WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.95: View larger version (38K): [in this window] [in a new window]  FIGURE 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 2."
Processing 00000000.tx.96: ROS induce higher molecular mass complex formation of the ASK1 signalosome. 

Phrase: "ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "higher molecular mass complex formation of the ASK1 signalosome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]
Processing 00000000.tx.97: A, gel filtration analysis of endogenous ASK1. 

Phrase: "A,"

Phrase: "gel filtration analysis of endogenous ASK1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.98: HEK293 cells (1.0 x 108 cells) were pretreated with or without 20 M propyl gallate (PG) for 20 min and then treated with 0.5 mM H2O2 for 15 or 30 min. 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(1.0 x 108 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "pretreated with"

Phrase: "or without 20 M propyl gallate (PG)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0033501:Propyl Gallate [Organic Chemical,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with 0.5 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 15"

Phrase: "or"

Phrase: "30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.99: The cell extracts were prepared as described under "Materials and Methods" and fractionated through a Superose6 10/300 GL column. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods"""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "fractionated through a Superose6 10/300 GL column."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0018229:GL [Geographic Area]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1423073:GL [Gene or Genome]
   744   C1427674:GL [Gene or Genome]
   744   C1706132:Column [Idea or Concept]
   744   C1979893:Fractionated [Qualitative Concept]
Processing 00000000.tx.100: Each fraction (0.5 ml/fraction) was subjected to protein precipitation using acetone/ethanol (1:4). 

Phrase: "Each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "(0.5 ml/fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "subjected to protein precipitation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0032931:Precipitation [Natural Phenomenon or Process]
   770   C0032932:Precipitation [Molecular Function]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1642401:% precipitation [Quantitative Concept]
   770   C2584299:Precipitation [Natural Phenomenon or Process]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "acetone/ethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2928658:Acetone / Ethanol [Pharmacologic Substance]
   861   C0001962:Ethanol [Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.101: The samples were analyzed by immunoblotting with the indicated antibodies. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.102: Apparent molecular mass is shown as described above. 

Phrase: "Apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "is"

Phrase: "shown as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.103: The elution positions of standard proteins are indicated at the top of the figure. 

Phrase: "The elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "positions of standard proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0733755:Position [Spatial Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]

Phrase: "are"

Phrase: "indicated at the top of the figure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1444656:Indicated [Finding]
   748   C1704458:Top [Spatial Concept]
Processing 00000000.tx.104: B, co-immunoprecipitation of Trx with ASK1. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "co-immunoprecipitation of Trx"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.105: The cell extracts from HEK293 cells (2.0 x 108 cells) were prepared as described under "Materials and Methods." 

Phrase: "The cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "extracts from HEK293 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C2936239:HEK293 Cells [Cell]
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(2.0 x 108 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.106: After fractionation on a Superose6 10/300 GL column, ASK1 containing fractions (Fig. 2A, lanes 5-8) were collected and immunoprecipitated with ASK1 antibody or control mouse IgG. 

Phrase: "After fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "on a Superose6 10/300 GL column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "ASK1 containing fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 2A,"

Phrase: "lanes 5-8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "immunoprecipitated with ASK1 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C1417014:ASK1 [Gene or Genome]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "control mouse IgG."
Processing 00000000.tx.107: The samples were then analyzed by immunoblotting with anti-ASK1 and anti-Trx antibodies. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with anti-ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417014:ASK1 [Gene or Genome]

Phrase: "and"

Phrase: "anti-Trx antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.108: The lower two panels (Input) show the presence of ASK1 and Trx by using 5% of the total cell extracts that were used to perform the immunoprecipitation. 

Phrase: "The lower two panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "(Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the presence of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Trx by"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   833   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5% of the total cell"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0007634:Cell [Cell]
   760   C0439084:>5 [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0728893:+5 [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.109: C, H2O2-induced activation of endogenous ASK1. 

Phrase: "C,"

Phrase: "H2O2-induced activation of endogenous ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]
Processing 00000000.tx.110: Subconfluent HEK293 cells were pretreated with or without 2 mM N-acetyl cysteine (NAC) or 20 M propyl gallate (PG) for 20 min and then treated with 0.5 mM H2O2 for the indicated periods. 

Phrase: "Subconfluent HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with"

Phrase: "or without 2 mM N-acetyl cysteine (NAC)"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0001047:acetylcysteine n [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   748   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   723 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "20 M propyl gallate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033501:Propyl Gallate [Organic Chemical,Pharmacologic Substance]

Phrase: "(PG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033501:Propyl Gallate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "treated with 0.5 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for the indicated periods."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.111: The cell extracts were subjected to immunoblotting with the indicated antibodies. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.112: D, H2O2-dependent dissociation of Trx from ASK1. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "H2O2-dependent dissociation of Trx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "from ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.113: An aliquot of each cell extract that was prepared for the gel filtration in E was immunoprecipitated with anti-Trx antibody or control rabbit IgG. 

Phrase: "An aliquot of each cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510844:Aliquot [Quantitative Concept]

Phrase: "extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "was"

Phrase: "prepared for the gel filtration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0008559:Gel Filtration [Laboratory Procedure]
   760   C0016107:filtration [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]
   726   C1521827:Prepare [Functional Concept]

Phrase: "in E"

Phrase: "was"

Phrase: "immunoprecipitated with anti-Trx antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "control rabbit IgG."
Processing 00000000.tx.114: The samples were then analyzed by immunoblotting with the indicated antibodies. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.115: The lower three panels (Input) show the presence of ASK1 and Trx by using 1.5% of the total cell extracts that were used to perform the immunoprecipitation. 

Phrase: "The lower three panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "(Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the presence of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "Trx by"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   833   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1.5% of the total cell"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0450316:1/5 [Quantitative Concept]
   753   C0007634:Cell [Cell]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2827734:1+ [Quantitative Concept]
   753   C2981698:1+ [Classification]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.116: E, co-immunoprecipitation of ASK1 with Trx. 

Phrase: "E,"

Phrase: "co-immunoprecipitation of ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   770   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "with Trx."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.117: The cell extracts from HEK293 cells were treated with or without 0.5 mM H2O2 for 15 min and then prepared as described under "Materials and Methods." 

Phrase: "The cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "extracts from HEK293 cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C2936239:HEK293 Cells [Cell]
   802   C0007592:Cell Extracts [Cell Component]
   770   C0007634:Cells [Cell]
   770   C2828366:Extract [Substance]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without 0.5 mM H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."""
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.118: After fractionation on a Superose6 10/300 GL column, each fraction was immunoprecipitated with anti-Trx antibody. 

Phrase: "After fractionation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016640:fractionation [Laboratory Procedure]
  1000   C0524811:fractionation [Therapeutic or Preventive Procedure]
  1000   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "on a Superose6 10/300 GL column,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1185738:Column [Body Part, Organ, or Organ Component]
   804   C1706132:Column [Idea or Concept]

Phrase: "each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "immunoprecipitated with anti-Trx antibody."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   726   C0301871:Immunoprecipitate [Immunologic Factor]
Processing 00000000.tx.119: The samples were then analyzed by immunoblotting with the indicated antibodies. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.120: Apparent molecular mass is shown as described above. 

Phrase: "Apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "is"

Phrase: "shown as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.121: The elution positions of standard proteins are indicated at the top of the figure. 

Phrase: "The elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "positions of standard proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0733755:Position [Spatial Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]

Phrase: "are"

Phrase: "indicated at the top of the figure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1444656:Indicated [Finding]
   748   C1704458:Top [Spatial Concept]
Processing 00000000.tx.122: WB, Western blot; 

Phrase: "WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:Wb [Quantitative Concept]

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.123: IP, immunoprecipitation.  

Phrase: "IP,"

Phrase: "immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.124: When cells were treated with H2O2, the ASK1 signalosome was eluted in higher molecular mass fractions, i.e. fractions 1-4 (>3,000 kDa; Fig. 2A, second and third panels). 

Phrase: "When"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with H2O2,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "the ASK1 signalosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1167160:signalosome [Cell Component]

Phrase: "was"

Phrase: "eluted in higher molecular mass fractions,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   773   C1264663:*Mass Fraction [Quantitative Concept]
   753   C0577559:Mass [Finding]
   753   C1264633:Fractions [Quantitative Concept]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1521991:Molecular [Qualitative Concept]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719 E C1554103:Fraction [Idea or Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "i.e. fractions 1-4"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   897   C1424188:I-4 [Gene or Genome]
   897   C1515147:I 4 [Cell]
   875   C0963236:I-1 [Amino Acid, Peptide, or Protein,Receptor]
   875   C1425233:I-1 [Gene or Genome]
   875   C3540559:I-1 [Gene or Genome]
   840   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "("

Phrase: ">3,000 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "; Fig. 2A,"

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "third panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.125: This elution profile was similar to that of exogenously expressed ASK1WT (Fig. 1C), suggesting that a certain population of exogenous ASK1 comprises an activated complex without any stimuli. 

Phrase: "This elution profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "was"

Phrase: "similar to that of exogenously expressed ASK1WT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a certain population of exogenous ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]

Phrase: "comprises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700400:Comprise [Activity]

Phrase: "an activated complex without any stimuli."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439855:Complex [Qualitative Concept]
   753   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.126: The shift of the ASK1-containing fractions was inhibited by the pretreatment of cells with anti-oxidants such as propyl gallate (Fig. 2A, bottom panel) and N-acetyl cysteine (data not shown). 

Phrase: "The shift of the ASK1-containing fractions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "was"

Phrase: "inhibited by the pretreatment of cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0007634:Cells [Cell]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3282337:Cells [Cell]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "with anti-oxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085403:Oxidants [Chemical Viewed Functionally]

Phrase: "such as propyl gallate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033501:Propyl Gallate [Organic Chemical,Pharmacologic Substance]

Phrase: "(Fig. 2A,"

Phrase: "bottom panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "N-acetyl cysteine"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0001047:N-Acetyl Cysteine [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
           Acetyl cysteine
   845 E C0699252:Mucomyst [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: The changes in the elution pattern of the ASK1 complex correlated well with the activation states of ASK1 and its downstream targets, JNK and p38 (Fig. 2C), as monitored by immunoblotting analysis using the aliquots of each cell extract prepared for the gel filtration. 

Phrase: "The changes in the elution pattern of the ASK1 complex"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   757   C1272746:changes pattern [Qualitative Concept]
   743   C0025320:The change [Physiologic Function]
   739   C0392747:changes [Functional Concept]
   739   C0443172:changes [Quantitative Concept]
   706 E C1705241:Change [Quantitative Concept]

Phrase: "correlated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlated [Qualitative Concept]

Phrase: "well with the activation states of ASK1"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0205170:Well [Qualitative Concept]
   748   C1301808:states [Geographic Area]
   748   C1417014:ASK1 [Gene or Genome]
   748   C1879547:Activation [Activity]
   748   C3146287:Well [Manufactured Object]
   714 E C1442792:State [Functional Concept]
   714 E C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "its downstream targets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]

Phrase: "JNK"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "and"

Phrase: "p38"

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "monitored by immunoblotting analysis"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   816   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblotting
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the aliquots of each cell extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1510844:Aliquot [Quantitative Concept]

Phrase: "prepared for the gel filtration."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0008559:Gel Filtration [Laboratory Procedure]
   760   C0016107:filtration [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]
   726   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.128: These results suggest that recruitment of additional component(s) to the HMM signaling complex of ASK1 may be involved in H2O2-induced activation of ASK1. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that recruitment of additional component"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2949735:Recruitment [Activity]

Phrase: "("

Phrase: "s) to the HMM signaling complex of ASK1"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   760   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   739   C0037083:Signaling [Cell Function]
   739   C0205250:High [Qualitative Concept]
   739   C0439855:Complex [Qualitative Concept]
   739   C0577559:Mass [Finding]
   739   C1299351:High [Qualitative Concept]
   739   C1306372:*Mass [Quantitative Concept]
   739   C1417014:ASK1 [Gene or Genome]
   739   C1521991:Molecular [Qualitative Concept]
   739   C1704241:Complex [Chemical Viewed Structurally]
   739   C2603362:S' [Clinical Attribute]
   739   C2700149:HIGH [Intellectual Product]
   739   C3537152:signaling [Biologic Function]
   722   C1519315:Signaling Molecule [Biologically Active Substance]
   706 E C1710082:Signal [Phenomenon or Process]

Phrase: "may"

Phrase: "be"

Phrase: "involved in H2O2-induced activation of ASK1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1417014:ASK1 [Gene or Genome]
   748   C1879547:Activation [Activity]
Processing 00000000.tx.129: To examine the binding states between Trx and ASK1 after ROS exposure, nontransfected HEK293 cells lysate was subjected to the coimmunoprecipitation analysis. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the binding states between Trx"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1301808:states [Geographic Area]
   726 E C1442792:State [Functional Concept]
   726 E C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "ASK1 after ROS exposure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1417014:ASK1 [Gene or Genome]

Phrase: "nontransfected HEK293 cells lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "subjected to the coimmunoprecipitation analysis."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1449705:Co-Immunoprecipitation [Laboratory Procedure]
   760   C1524024:analysis [Functional Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.130: As previously demonstrated in ASK1-transfected HEK293 cells (6), we confirmed that H2O2 treatment disrupted the endogenous interaction between Trx and ASK1 in nontransfected HEK293 cells (Fig. 2D). 

Phrase: "As"

Phrase: "previously"

Phrase: "demonstrated in ASK1-transfected HEK293 cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C2936239:HEK293 Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C1417014:ASK1 [Gene or Genome]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(6"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that H2O2 treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "disrupted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:Disrupted [Qualitative Concept]

Phrase: "the endogenous interaction between Trx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "ASK1 in nontransfected HEK293 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1417014:ASK1 [Gene or Genome]

Phrase: "(Fig. 2D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: ")."
Processing 00000000.tx.131: When nontransfected HEK293 cells lysate was analyzed by gel filtration, endogenous Trx was found to exist in all fractions regardless of the presence of ASK1 (Fig. 2E, second and fourth panels). 

Phrase: "When"

Phrase: "nontransfected HEK293 cells lysate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "was"

Phrase: "analyzed by gel filtration,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008559:Gel Filtration [Laboratory Procedure]
   770   C0016107:filtration [Laboratory Procedure]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C0936012:Analyzed [Research Activity]
   770   C1382104:Gel [Substance]

Phrase: "endogenous Trx"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exist in all fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1264633:Fractions [Quantitative Concept]
   770   C2987476:Exist [Conceptual Entity]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "regardless of the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "(Fig. 2E,"

Phrase: "second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "and"

Phrase: "fourth panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.132: Co-immunoprecipitation analyses of individual fractions showed that the interaction of ASK1 and Trx in unstimulated cells was clearly detectable in the HMM fractions almost in parallel with the amount of ASK1 in each fractions (Fig. 2E, top panel, lanes 5-10; compare with Fig. 2A, top panel); 

Phrase: "Co-immunoprecipitation analyses of individual fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the interaction of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Trx in unstimulated cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "clearly detectable in the HMM fractions"

Phrase: "almost in parallel with the amount of ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C2348042:Parallel [Qualitative Concept]
   744   C2826345:PARALLEL [Research Activity]

Phrase: "in each fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 2E,"

Phrase: "top panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "lanes 5-10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ";"

Phrase: "compare with Fig. 2A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1707455:Compare [Activity]

Phrase: "top panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.133: however, Trx-ASK1 interaction was strongly reduced in H2O2-treated cells (Fig. 2E, third panel). 

Phrase: "however,"

Phrase: "Trx-ASK1 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "was"

Phrase: "strongly"

Phrase: "reduced in H2O2-treated cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   760   C0007634:Cells [Cell]
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1522326:Treated [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1292734:TREAT [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 2E,"

Phrase: "third panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.134: This indicates that the H2O2-induced higher molecular mass complex of ASK1 (corresponding to lanes 1-4 of the second and third panels in Fig. 2A) does not contain Trx. 

Phrase: "This"

Phrase: "indicates"

Phrase: "that"

Phrase: "the H2O2-induced higher molecular mass complex of ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0439855:Complex [Qualitative Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "("

Phrase: "corresponding to lanes 1-4 of the second"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205436:Second [Quantitative Concept]
   744   C0457385:Second [Temporal Concept]
   744   C0565930:/second [Quantitative Concept]
   744   C1561503:second [Idea or Concept]
   744   C1705190:Second [Qualitative Concept]
   731   C0175668:Secondary to [Temporal Concept]
   711   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "third panels in Fig. 2A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441833:Panel [Idea or Concept]
   760   C1999270:Panel [Intellectual Product]
   760   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "Trx."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.135: These results suggest that dissociation of Trx from and reciprocal association of additional component(s) to the preexisting HMM signaling complex of ASK1 may occur during ROS-induced activation of ASK1. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that dissociation of Trx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "from"

Phrase: "and"

Phrase: "reciprocal association of additional component"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "("

Phrase: "s) to the preexisting HMM signaling complex of ASK1"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   756   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   738   C0037083:Signaling [Cell Function]
   738   C0205250:High [Qualitative Concept]
   738   C0439855:Complex [Qualitative Concept]
   738   C0577559:Mass [Finding]
   738   C1299351:High [Qualitative Concept]
   738   C1306372:*Mass [Quantitative Concept]
   738   C1417014:ASK1 [Gene or Genome]
   738   C1521991:Molecular [Qualitative Concept]
   738   C1704241:Complex [Chemical Viewed Structurally]
   738   C2347662:Pre-existing [Qualitative Concept]
   738   C2603362:S' [Clinical Attribute]
   738   C2700149:HIGH [Intellectual Product]
   738   C3537152:signaling [Biologic Function]
   718   C1519315:Signaling Molecule [Biologically Active Substance]
   704 E C1710082:Signal [Phenomenon or Process]

Phrase: "may"

Phrase: "occur during ROS-induced activation of ASK1."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   742   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0205263:Induced [Functional Concept]
   742   C0205332:Reactive [Qualitative Concept]
   742   C1417014:ASK1 [Gene or Genome]
   742   C1705920:Species [Conceptual Entity]
   742   C1709305:Occur [Activity]
   742   C1879547:Activation [Activity]
   742   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.136: View larger version (40K): [in this window] [in a new window]  FIGURE 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 3."
Processing 00000000.tx.137: TNF also induces higher molecular mass complex formation of the ASK1 signalosome. 

Phrase: "TNF also"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "higher molecular mass complex formation of the ASK1 signalosome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]
Processing 00000000.tx.138: A, TNF-induced activation of endogenous ASK1. 

Phrase: "A,"

Phrase: "TNF-induced activation of endogenous ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]
Processing 00000000.tx.139: Subconfluent HEK293 cells were treated with 100 ng/ml TNF for the indicated periods. 

Phrase: "Subconfluent HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 100 ng/ml TNF"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for the indicated periods."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.140: The cell extracts were subjected to immunoblotting with anti-ASK1 antibody and phospho-ASK1 antibody. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-ASK1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "phospho-ASK1 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.141: B, TNF-induced interaction between TRAF2 and ASK1. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "TNF-induced interaction between TRAF2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.142: HEK293 cells were transiently transfected with ASK1WT-HA in 6-well plates. 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with ASK1WT-HA"

Phrase: "in 6-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.143: After 36 h, the cells were treated with 100 ng/ml TNF for the indicated periods. 

Phrase: "After 36 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 100 ng/ml TNF"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for the indicated periods."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.144: The cell extracts were immunoprecipitated with anti-TRAF2 antibody followed by immunoblotting with the indicated antibodies. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoprecipitated with anti-TRAF2 antibody"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   849   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   764   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0034805:antibody receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   762   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   708   C0301871:Immunoprecipitate [Immunologic Factor]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.145: The lower two panels (Input) show that appropriate expression of proteins by using 2.5% of the cell extracts that was used to perform the immunoprecipitation. 

Phrase: "The lower two panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "(Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that appropriate expression of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2.5% of the cell"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0450346:2 5 [Quantitative Concept]
   760   C0007634:Cell [Cell]
   760   C0740116:+2 [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.146: C, gel filtration analysis of endogenous ASK1. 

Phrase: "C,"

Phrase: "gel filtration analysis of endogenous ASK1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.147: HEK 293 cells (1.0x 108 cells) were treated with 100 ng/ml TNF for 30 min. 

Phrase: "HEK 293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK 293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(1.0x 108 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "treated with 100 ng/ml TNF"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0439275:ng/mL [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.148: Gel filtration analysis of endogenous ASK1 was performed as described for Fig. 

Phrase: "Gel filtration analysis of endogenous ASK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described for Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.149: 2A. 

Phrase: "2A."
Processing 00000000.tx.150: D, the kinetics of the ASK1 activation by H2O2. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the kinetics of the ASK1 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022702:Kinetics [Natural Phenomenon or Process]
   753   C0220865:kinetics [Functional Concept]
   753   C2825046:Kinetics [Occupation or Discipline]

Phrase: "by H2O2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
Processing 00000000.tx.151: Subconfluent HEK293 cells were treated with 0.5 mM H2O2 for the indicated periods. 

Phrase: "Subconfluent HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C2936239:HEK293 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0.5 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for the indicated periods."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.152: The cell extracts were subjected to immunoblotting with anti-ASK1 antibody and phospho-ASK1 antibody. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with anti-ASK1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "phospho-ASK1 antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.153: E, H2O2-induced interaction of TRAF2 and ASK1. 

Phrase: "E,"

Phrase: "H2O2-induced interaction of TRAF2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.154: HEK293 cells were transiently transfected with ASK1WT-HA in 6-well plates. 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with ASK1WT-HA"

Phrase: "in 6-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.155: After 36 h, the cells were treated with 0.5 mM H2O2 for the indicated periods. 

Phrase: "After 36 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0.5 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for the indicated periods."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.156: The cell extracts were immunoprecipitated with anti-TRAF2 antibody followed by immunoblotting with the indicated antibodies. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoprecipitated with anti-TRAF2 antibody"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   849   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   849   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   764   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   762   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0034805:antibody receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   762   C0332281:Associated with [Qualitative Concept]
           Associated
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   708   C0301871:Immunoprecipitate [Immunologic Factor]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1706221:Associate [Professional or Occupational Group]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.157: The lower two panels (Input) show the appropriate expression of proteins by using 2.5% of the cell extracts that were used to perform the immunoprecipitation. 

Phrase: "The lower two panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "(Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the appropriate expression of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2.5% of the cell"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0450346:2 5 [Quantitative Concept]
   760   C0007634:Cell [Cell]
   760   C0740116:+2 [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.158: WB, Western blot; 

Phrase: "WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:Wb [Quantitative Concept]

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.159: IP, immunoprecipitation.  

Phrase: "IP,"

Phrase: "immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.160: View larger version (42K): [in this window] [in a new window]  FIGURE 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 4."
Processing 00000000.tx.161: TRAF2, TRAF6 but not TRAF5 are required for ROS-induced activation of the ASK1-JNK/p38 pathways. 

Phrase: "TRAF2,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "but"

Phrase: "not TRAF5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420889:TRAF5 [Gene or Genome]

Phrase: "are"

Phrase: "required for ROS-induced activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C0205332:Reactive [Qualitative Concept]
   748   C1514873:Required [Functional Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C1879547:Activation [Activity]

Phrase: "of the ASK1-JNK/p38 pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1621396:Pathways, JNK [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.162: A, equivalent expression of ASK1 in different MEFs. 

Phrase: "A,"

Phrase: "equivalent expression of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in different MEFs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.163: Extracts from indicated MEFs (100-mm plate) were immunoprecipitated with anti-ASK1 antibody or control IgG followed by immunoblotting with anti-ASK1 antibody (upper panel). 

Phrase: "Extracts from indicated MEFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C2828366:Extract [Substance]

Phrase: "(100-mm plate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "immunoprecipitated with anti-ASK1 antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C1417014:ASK1 [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "control IgG"

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with anti-ASK1 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.164: The lower panel shows that appropriate expression of p38 by using 5% of the cell extracts that was used to perform the immunoprecipitation. 

Phrase: "The lower panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that appropriate expression of p38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5% of the cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007634:Cell [Cell]
   770   C0439084:>5 [Quantitative Concept]
   770   C0728893:+5 [Quantitative Concept]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.165: B, requirement of TRAF2, TRAF5, and TRAF6 for H2O2-induced activation of ASK1. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "requirement of TRAF2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1514873:Requirement [Functional Concept]
   731   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   731   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "TRAF5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "and"

Phrase: "TRAF6 for H2O2-induced activation of ASK1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1336666:TRAF6 [Gene or Genome]
Processing 00000000.tx.166: C and D, requirement of TRAF2 (C) and TRAF6 (D) for H2O2-induced activation of JNK/p38. 

Phrase: "C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "requirement of TRAF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1514873:Requirement [Functional Concept]
   731   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   731   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "("

Phrase: "D) for H2O2-induced activation of JNK/p38."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0205263:Induced [Functional Concept]
   744   C1150587:JNK [Molecular Function]
   744   C1367731:JNK [Gene or Genome]
   744   C1705632:JNK [Gene or Genome]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.167: MEFs were treated with 0.5 mM H2O2 for the indicated periods. 

Phrase: "MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1516828:Mouse Embryonic Fibroblast [Tissue]
   896   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "treated with 0.5 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for the indicated periods."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.168: The cell extracts were subjected to immunoblotting with the indicated antibodies. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.169: E and F, requirement of TRAF6 for ROS but not endoplasmic reticulum stress-induced activation of ASK1. 

Phrase: "E"

Phrase: "and"

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "requirement of TRAF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1514873:Requirement [Functional Concept]

Phrase: "for ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "but"

Phrase: "not endoplasmic reticulum stress-induced activation of ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]
Processing 00000000.tx.170: Splenocyte-derived macrophages (2 x 106) from Traf6+/- or Traf6-/- (Traf6-/- #1 and #2; independently prepared cells) mice were treated with 1.0 mM H2O2 for 30 min (E) or 20 M thapsigargin (Tg) for 30 min (F). 

Phrase: "Splenocyte-derived macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024432:Macrophages [Cell]
   827   C1546706:Macrophages [Intellectual Product]
   827   C1550652:Macrophages [Body Substance]

Phrase: "(2 x 106"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "from Traf6+/-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "or"

Phrase: "Traf6-/-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "(Traf6-/- #1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1336666:TRAF6 [Gene or Genome]

Phrase: "and #"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "; independently prepared cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "treated with 1.0 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 30 min (E)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: "or"

Phrase: "20 M thapsigargin (Tg) for 30 min (F)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.171: The cell extracts were subjected to immunoblotting with the indicated antibodies. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "subjected to immunoblotting"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.172: WB, Western blot; 

Phrase: "WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:Wb [Quantitative Concept]

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.173: IP, immunoprecipitation; 

Phrase: "IP,"

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.174: WT, wild type.  

Phrase: "WT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "wild type."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.175: TNF Also Induces Higher Molecular Mass Complex Formation of ASK1We have previously demonstrated that TRAF2 interacts with and activates ASK1 in TNF signaling (5). 

Phrase: "TNF Also"

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Higher Molecular Mass Complex Formation of ASK1We"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "have"

Phrase: "previously"

Phrase: "demonstrated"

Phrase: "that TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "interacts with"

Phrase: "and"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1 in TNF signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1417014:ASK1 [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.176: We have also reported that ROS-dependent prior dissociation of Trx is required for the TNF-induced TRAF2-ASK1 interaction and activation of ASK1 (6, 17). 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that ROS-dependent prior dissociation of Trx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "is"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "for the TNF-induced TRAF2-ASK1 interaction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C1704675:Interaction [Functional Concept]
   720   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   720   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "and"

Phrase: "activation of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "(6,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.177: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.178: 3A shows that TNF activated endogenous ASK1 in HEK293 cells within 15 min and peaked at 30 min after the treatment with TNF. 

Phrase: "3A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that TNF"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "endogenous ASK1 in HEK293 cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1417014:ASK1 [Gene or Genome]

Phrase: "within 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "peaked at 30 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0444505:peaked [Quantitative Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "after the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with TNF."
Processing 00000000.tx.179: The interaction between exogenously expressed ASK1 (ASK1-HA), and endogenous TRAF2 was also found to peak at 30 min after the treatment with TNF in HEK293 cells, and ASK1 co-immunoprecipitated with TRAF2 was found to be phosphorylated as determined by immunoblotting with phospho-ASK1 antibody (Fig. 3B). 

Phrase: "The interaction between exogenously expressed ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "(ASK1-HA"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "endogenous TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   947   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   947   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   827   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C0332281:Associated [Qualitative Concept]
   799   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   766 E C0750490:Associate [Idea or Concept]
   766 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "also"

Phrase: "found to peak"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0150312:Found [Quantitative Concept]
   790   C0444505:Peak [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "at 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "after the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with TNF"

Phrase: "in HEK293 cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "co-immunoprecipitated with TRAF2"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   869   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   770   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   711   C0301871:Immunoprecipitate [Immunologic Factor]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated"

Phrase: "as"

Phrase: "determined by immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "with phospho-ASK1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.180: When TNF-treated cell extract was analyzed by the gel filtration column, a shift of the ASK1-containing HMM fractions toward the higher molecular mass fractions was clearly observed in a TNF-dependent manner (Fig. 3C). 

Phrase: "When"

Phrase: "TNF-treated cell extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2828366:Extract [Substance]

Phrase: "was"

Phrase: "analyzed by the gel filtration column,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0008559:Gel Filtration [Laboratory Procedure]
   753   C0016107:filtration [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0936012:Analyzed [Research Activity]
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1382104:Gel [Substance]
   753   C1706132:Column [Idea or Concept]

Phrase: "a shift of the ASK1-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0333051:Shift [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "HMM fractions toward the higher molecular mass fractions"

Phrase: "was"

Phrase: "clearly"

Phrase: "observed in a TNF-dependent manner"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.181: These results suggested that TNF activates the static HMM ASK1 complex by recruiting additional components including TRAF2. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that TNF"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "the static HMM ASK1 complex by recruiting additional components"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0439855:Complex [Qualitative Concept]
   738   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "TRAF2."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.182: ASK1 Interacts with TRAF2 in a ROS-dependent MannerThe similarity between H2O2- and TNF-induced changes in the ASK1 signaling complex (Figs. 2A and 3C), together with the finding that TNF-induced activation of ASK1 depends largely on ROS (6, 17) prompted us to examine whether TRAF2 may also be involved in the mechanism of ROS-induced activation of ASK1. 

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "Interacts with TRAF2"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   897   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   778   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   774   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a ROS-dependent MannerThe similarity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2348205:Similarity [Qualitative Concept]

Phrase: "between H2O2-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "and"

Phrase: "TNF-induced changes in the ASK1 signaling complex"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0392747:changes [Functional Concept]
   744   C0443172:changes [Quantitative Concept]
   711 E C1705241:Change [Quantitative Concept]

Phrase: "(Figs. 2A"

Phrase: "and"

Phrase: "3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "together with the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that TNF-induced activation of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "depends"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0725813:depend [Medical Device]

Phrase: "largely on ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   862   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   760   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0205332:Reactive [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]

Phrase: "(6,"

Phrase: "17"

Phrase: ")"

Phrase: "prompted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0871157:prompted [Functional Concept]
   966 E C1602245:Prompt [Pharmacologic Substance]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "may"

Phrase: "also"

Phrase: "be"

Phrase: "involved in the mechanism of ROS-induced activation of ASK1."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   736   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   736   C0205263:Induced [Functional Concept]
   736   C0205332:Reactive [Qualitative Concept]
   736   C0441712:Mechanism [Functional Concept]
   736   C1314939:Involved [Functional Concept]
   736   C1417014:ASK1 [Gene or Genome]
   736   C1705920:Species [Conceptual Entity]
   736   C1706376:Mechanism [Manufactured Object]
   736   C1879547:Activation [Activity]
Processing 00000000.tx.183: In support of this idea, it has recently been reported that TRAF2 is required for H2O2-induced JNK activation and cell death (38). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this idea,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "it"

Phrase: "has"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "required for H2O2-induced JNK activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C1150587:JNK [Molecular Function]
   753   C1367731:JNK [Gene or Genome]
   753   C1514873:Required [Functional Concept]
   753   C1705632:JNK [Gene or Genome]
   753   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.184: We therefore examined whether TRAF2 is involved in H2O2-induced activation of ASK1. 

Phrase: "We therefore"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "is"

Phrase: "involved in H2O2-induced activation of ASK1."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C1314939:Involved [Functional Concept]
   748   C1417014:ASK1 [Gene or Genome]
   748   C1879547:Activation [Activity]
Processing 00000000.tx.185: In parallel with the time course of H2O2-induced activation of ASK1 (Fig. 3D), ASK1 was co-immunoprecipitated with TRAF2 in an H2O2-dependent manner, and co-immunoprecipitated ASK1 was phosphorylated and thus activated (Fig. 3E). 

Phrase: "In parallel with the time course of H2O2-induced activation of ASK1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0150312:In [Quantitative Concept]
   736   C0332285:In [Spatial Concept]
   736   C2348042:Parallel [Qualitative Concept]
   736   C2826345:PARALLEL [Research Activity]

Phrase: "(Fig. 3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450363:3D [Spatial Concept]
   861   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "was"

Phrase: "co-immunoprecipitated with TRAF2"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   869   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   869   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   770   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   767   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   711   C0301871:Immunoprecipitate [Immunologic Factor]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in an H2O2-dependent manner,"

Phrase: "and"

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "was"

Phrase: "phosphorylated"

Phrase: "and"

Phrase: "thus"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "(Fig. 3E"

Phrase: ")."
Processing 00000000.tx.186: These results strongly suggested that the molecular components responsible for H2O2-induced larger complex formation of the ASK1 signalosome include TRAF2. 

Phrase: "These results strongly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the molecular components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "responsible for H2O2-induced larger complex formation of the ASK1 signalosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1273518:Responsible [Finding]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "TRAF2."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.187: View larger version (43K): [in this window] [in a new window]  FIGURE 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(43K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 5."
Processing 00000000.tx.188: Recruitment of TRAF6 is responsible for H2O2-induced larger complex formation of the ASK1 signalosome. 

Phrase: "Recruitment of TRAF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2949735:Recruitment [Activity]

Phrase: "is"

Phrase: "responsible for H2O2-induced larger complex formation of the ASK1 signalosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1273518:Responsible [Finding]
Processing 00000000.tx.189: A, H2O2-induced interaction between ASK1 and TRAF6. 

Phrase: "A,"

Phrase: "H2O2-induced interaction between ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "TRAF6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]
Processing 00000000.tx.190: HEK293 cells were transiently transfected with ASK1WT-HA in 6-well plates. 

Phrase: "HEK293 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2936239:HEK293 Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transiently"

Phrase: "transfected with ASK1WT-HA"

Phrase: "in 6-well plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1139930:plates [Medical Device]
   793 E C0005971:Plate [Medical Device]
   793 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.191: After 36 h, the cells were treated with 0.5 mM H2O2 for the indicated periods. 

Phrase: "After 36 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 0.5 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for the indicated periods."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]
Processing 00000000.tx.192: The cell extracts were immunoprecipitated with anti-TRAF6 antibody followed by immunoblotting with the indicated antibodies. 

Phrase: "The cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "immunoprecipitated with anti-TRAF6 antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1336666:TRAF6 [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.193: The lower panels (Input) show the appropriate expression of proteins by using 2.5% of the cell extracts that was used to perform the immunoprecipitation. 

Phrase: "The lower panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: "(Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the appropriate expression of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2.5% of the cell"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0450346:2 5 [Quantitative Concept]
   760   C0007634:Cell [Cell]
   760   C0740116:+2 [Quantitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2827735:2+ [Quantitative Concept]
   760   C2981700:2+ [Classification]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.194: B, endogenous interaction between ASK1 and TRAF6. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "endogenous interaction between ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "TRAF6."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]
Processing 00000000.tx.195: An aliquot of each cell extract that was prepared for the gel filtration in Fig. 

Phrase: "An aliquot of each cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510844:Aliquot [Quantitative Concept]

Phrase: "extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "was"

Phrase: "prepared for the gel filtration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0008559:Gel Filtration [Laboratory Procedure]
   760   C0016107:filtration [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]
   726   C1521827:Prepare [Functional Concept]

Phrase: "in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.196: 2E was immunoprecipitated with anti-TRAF6 antibody or control rabbit IgG. 

Phrase: "2E"

Phrase: "was"

Phrase: "immunoprecipitated with anti-TRAF6 antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1336666:TRAF6 [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "or"

Phrase: "control rabbit IgG."
Processing 00000000.tx.197: The samples were then analyzed by immunoblotting with the indicated antibodies. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with the indicated antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.198: The lower three panels (Input) show the presence of ASK1 and TRAF6 by using 0.5% of the total cell extracts that were used to perform the immunoprecipitation. 

Phrase: "The lower three panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441833:Panel [Idea or Concept]
   827   C1999270:Panel [Intellectual Product]
   827   C3537156:Panel [Manufactured Object]

Phrase: "(Input"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708517:Input [Conceptual Entity]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the presence of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "TRAF6 by"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1336666:TRAF6 [Gene or Genome]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.5% of the total cell"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0007634:Cell [Cell]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "extracts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2828366:Extract [Substance]

Phrase: "that"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "the immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.199: C-F, gel filtration analysis of WT (C-E) and Traf6-/- MEFs (F). 

Phrase: "C-F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "gel filtration analysis of WT (C-E)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "Traf6-/- MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]

Phrase: "(F)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.200: Both MEFs were infected with adenoviruses encoding HA-tagged ASK1 WT (6). 

Phrase: "Both MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1516828:Mouse Embryonic Fibroblast [Tissue]
   896   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "infected with adenoviruses"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0001483:Adenoviruses [Virus]
   790   C0439663:Infected [Functional Concept]
   756 E C0001486:Adenovirus [Disease or Syndrome]
   756 E C1552907:adenovirus, NOS [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "HA-tagged ASK1 WT (6"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C1417014:ASK1 [Gene or Genome]
   804   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   804   C1708632:Tagged [Qualitative Concept]
   804   C2700323:WT [Fish]
   771 E C0037293:Tag [Neoplastic Process]
   771 E C0181496:Tag [Manufactured Object]
   771 E C1710492:TAG [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.201: After 36 h, the cell extracts were treated with or without 0.5 mM H2O2 for 15 min and then prepared as described under "Materials and Methods," and each lysate was fractionated through a Superose6 10/300 GL column. 

Phrase: "After 36 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "the cell extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007592:Cell Extracts [Cell Component]
   827   C2828366:Extract [Substance]

Phrase: "were"

Phrase: "treated with"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C1522326:Treated [Functional Concept]
   799 E C1292734:TREAT [Functional Concept]

Phrase: "or without 0.5 mM H2O2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444499:0/5 [Quantitative Concept]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: """"

Phrase: "and"

Phrase: "each lysate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881488:Lysate [Physical Object]

Phrase: "was"

Phrase: "fractionated through a Superose6 10/300 GL column."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0018229:GL [Geographic Area]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1423073:GL [Gene or Genome]
   744   C1427674:GL [Gene or Genome]
   744   C1706132:Column [Idea or Concept]
   744   C1979893:Fractionated [Qualitative Concept]
Processing 00000000.tx.202: Each fraction was analyzed by immunoblotting with anti-HA antibody (C and F) or phospho-ASK1 antibody (D) or was immunoprecipitated with anti-TRAF6 antibody followed by immunoblotting with anti-HA antibody (E). 

Phrase: "Each fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "analyzed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with anti-HA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(C"

Phrase: "and"

Phrase: "F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "or"

Phrase: "phospho-ASK1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "D)"

Phrase: "or"

Phrase: "was"

Phrase: "immunoprecipitated with anti-TRAF6 antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1336666:TRAF6 [Gene or Genome]
   726   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "followed by immunoblotting"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332283:Followed by [Temporal Concept]
           followed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "with anti-HA antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.203: The apparent molecular mass is shown as described above. 

Phrase: "The apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "is"

Phrase: "shown as described above."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1552738:described [Idea or Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.204: The elution positions of standard proteins are indicated at the top of the figure. 

Phrase: "The elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "positions of standard proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0733755:Position [Spatial Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]

Phrase: "are"

Phrase: "indicated at the top of the figure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1444656:Indicated [Finding]
   748   C1704458:Top [Spatial Concept]
Processing 00000000.tx.205: WB, Western blot; 

Phrase: "WB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:Wb [Quantitative Concept]

Phrase: "Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.206: IP, immunoprecipitation.  

Phrase: "IP,"

Phrase: "immunoprecipitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]
Processing 00000000.tx.207: TRAF2 and TRAF6 but Not TRAF5 Are Required for ROS-induced Activation of the ASK1-JNK/p38 PathwaysAmong the TRAF family members, not only TRAF2 but also TRAF5 and TRAF6 activate ASK1 (5). 

Phrase: "TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "but"

Phrase: "Not TRAF5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420889:TRAF5 [Gene or Genome]

Phrase: "Are"

Phrase: "Required for ROS-induced Activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0205263:Induced [Functional Concept]
   748   C0205332:Reactive [Qualitative Concept]
   748   C1514873:Required [Functional Concept]
   748   C1705920:Species [Conceptual Entity]
   748   C1879547:Activation [Activity]

Phrase: "of the ASK1-JNK/p38 PathwaysAmong"

Phrase: "the TRAF family members,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "not only TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   818   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C0332281:Associated [Qualitative Concept]
   795   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   795   C1521761:Factor [Functional Concept]
   795   C2827422:Factor [Conceptual Entity]
   762 E C0750490:Associate [Idea or Concept]
   762 E C1706221:Associate [Professional or Occupational Group]

Phrase: "but"

Phrase: "also TRAF5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420889:TRAF5 [Gene or Genome]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.208: Furthermore, our recent report demonstrated that ROS-dependent interaction of TRAF6 and ASK1 is crucial for lipopolysaccharide-induced activation of the ASK1-p38 pathway (36). 

Phrase: "Furthermore,"

Phrase: "our recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "demonstrated"

Phrase: "that ROS-dependent interaction of TRAF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "is"

Phrase: "crucial for lipopolysaccharide-induced activation of the ASK1-p38 pathway"

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.209: We thus explored the possibility of whether TRAF2, TRAF5, and TRAF6 are involved in ROS-induced ASK1 activation. 

Phrase: "We thus"

Phrase: "explored"

Phrase: "the possibility of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0332149:Possible [Qualitative Concept]
   718   C1705910:Possible [Qualitative Concept]
   718   C2362652:Possible [Qualitative Concept]

Phrase: "whether"

Phrase: "TRAF2,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "TRAF5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "are"

Phrase: "involved in ROS-induced ASK1 activation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0205263:Induced [Functional Concept]
   744   C0205332:Reactive [Qualitative Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1417014:ASK1 [Gene or Genome]
   744   C1705920:Species [Conceptual Entity]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.210: To examine the requirement of TRAFs for ROS-induced ASK1 activation, we analyzed MEFs deficient for TRAF2 (39), TRAF5 (28) and TRAF6 (29, 33). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the requirement of TRAFs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "for ROS-induced ASK1 activation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1879547:Activation [Activity]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1516828:Mouse Embryonic Fibroblast [Tissue]
   896   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]

Phrase: "deficient for TRAF2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0011155:Deficient [Functional Concept]
   748   C1636779:% deficient [Quantitative Concept]
   731   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   731   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "(39"

Phrase: ")"

Phrase: ","

Phrase: "TRAF5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "(28"

Phrase: ")"

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "(29,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.211: Although the expression of endogenous ASK1 was relatively low in MEFs, almost equivalent expression of endogenous ASK1 in Traf2-/-, Traf5-/-, Traf6-/-, and wild-type MEFs was confirmed by immunoblotting following immunoprecipitation (Fig. 4A). 

Phrase: "Although"

Phrase: "the expression of endogenous ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "relatively low in MEFs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205251:low [Qualitative Concept]
   753   C1299352:Low [Qualitative Concept]
   753   C1550472:low [Idea or Concept]

Phrase: "almost equivalent expression of endogenous ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in Traf2-/-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0258441:TRAF2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TRAF2 [Gene or Genome]

Phrase: "Traf5-/-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "Traf6-/-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "and"

Phrase: "wild-type MEFs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   873   C1516828:Mouse Embryonic Fibroblast [Tissue]
   836   C1522260:Mouse Fibroblast [Cell]
   804   C0016030:Fibroblasts [Cell]
   717   C1520150:Wild Type Mouse [Mammal]

Phrase: "was"

Phrase: "confirmed by immunoblotting"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.212: H2O2-induced activation of ASK1 was strongly suppressed in TRAF2- and TRAF6-deficient but not TRAF5-deficient MEFs when compared with each of genotype-matched control MEFs (Fig. 4B). 

Phrase: "H2O2-induced activation of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "strongly"

Phrase: "suppressed in TRAF2-"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   897   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   778   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0332281:Associated [Qualitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1260953:Suppressed [Functional Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6-deficient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011155:Deficient [Functional Concept]
   861   C1636779:% deficient [Quantitative Concept]

Phrase: "but"

Phrase: "not TRAF5-deficient MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   850   C1516828:Mouse Embryonic Fibroblast [Tissue]
   822   C1522260:Mouse Fibroblast [Cell]
   799   C0016030:Fibroblasts [Cell]

Phrase: "when"

Phrase: "compared with each of genotype-matched control MEFs"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   771   C1516828:Mouse Embryonic Fibroblast [Tissue]
   741   C1522260:Mouse Fibroblast [Cell]
   739   C0013935:Embryonic [Embryonic Structure]
   739   C0016030:Fibroblasts [Cell]
   739   C0017431:Genotype [Organism Attribute]
   739   C0025914:Mouse [Mammal]
   739   C0025929:mouse [Mammal]
   739   C0026809:Mouse [Mammal]
   739   C0150103:matched [Research Activity]
   739   C0243148:control [Qualitative Concept]
   739   C1550141:Control [Substance]
   739   C1707455:Compared [Activity]
   739   C1708943:Matched [Qualitative Concept]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.213: Consistently, H2O2-induced activations of JNK and p38 were also inhibited in TRAF2- and TRAF6-deficient MEFs (Fig. 4, C and D). 

Phrase: "Consistently,"

Phrase: "H2O2-induced activations of JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "p38"

Phrase: "were"

Phrase: "also"

Phrase: "inhibited in TRAF2-"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   897   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   778   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0332281:Associated [Qualitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6-deficient MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   873   C1516828:Mouse Embryonic Fibroblast [Tissue]
   836   C1522260:Mouse Fibroblast [Cell]
   804   C0016030:Fibroblasts [Cell]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.214: These results suggested that TRAF2 and TRAF6 but not TRAF5 are required for H2O2-induced activation of the ASK1-JNK/p38 pathways. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "but"

Phrase: "not TRAF5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1420889:TRAF5 [Gene or Genome]

Phrase: "are"

Phrase: "required for H2O2-induced activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0205263:Induced [Functional Concept]
   760   C1514873:Required [Functional Concept]
   760   C1879547:Activation [Activity]

Phrase: "of the ASK1-JNK/p38 pathways."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1621396:Pathways, JNK [Molecular Function]
   812   C1704259:Pathways [Molecular Function]
   812   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.215: Nevertheless, the relatively late (60 or 90 min) responses of JNK and p38 to H2O2 in TRAF2- and TRAF6-deficient MEFs were only partially impaired (Fig. 4, C and D), suggesting that H2O2 evoked secondary signals, which induce TRAF2- or TRAF6-independent activations of the JNK and p38 pathways in the late phase. 

Phrase: "Nevertheless,"

Phrase: "the relatively late"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205087:Late [Temporal Concept]

Phrase: "(60"

Phrase: "or"

Phrase: "90 min) responses of JNK"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "p38 to H2O2"

Phrase: "in TRAF2-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6-deficient MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   873   C1516828:Mouse Embryonic Fibroblast [Tissue]
   836   C1522260:Mouse Fibroblast [Cell]
   804   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "only partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "evoked"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444748:Evoked [Qualitative Concept]

Phrase: "secondary signals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "which"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "TRAF2-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "TRAF6-independent activations of the JNK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "p38 pathways in the late phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathways [Molecular Function]
   753   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.216: Impairment of ASK1 activation in TRAF2-deficient cells treated with H2O2 for 90 min was also limited probably for the same reason, whereas H2O2-induced ASK1 activation was abolished throughout the time course tested in TRAF6-deficient cells (Fig. 4B). 

Phrase: "Impairment of ASK1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0684336:Impairment [Pathologic Function]

Phrase: "in TRAF2-deficient cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   860   C1514760:Receptor Cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]
   747   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   747   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "treated with H2O2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "for 90 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "also"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: "probably for the same reason,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392360:Reason [Idea or Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0750492:Probably [Idea or Concept]

Phrase: "whereas"

Phrase: "H2O2-induced ASK1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "abolished throughout the time course"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0449247:Time course [Temporal Concept]
   760   C0040223:Time [Temporal Concept]
   760   C0750729:Course [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "tested in TRAF6-deficient cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   760   C0007634:Cells [Cell]
   760   C0011155:Deficient [Functional Concept]
   760   C0392366:tested [Intellectual Product]
   760   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1336666:TRAF6 [Gene or Genome]
   760   C1636779:% deficient [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.217: This contrast in the extent of impairment of ASK1 activation suggests that TRAF6 is more critically required for H2O2-induced ASK1 activation than TRAF2. 

Phrase: "This contrast in the extent of impairment of ASK1 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1979874:Contrast [Qualitative Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "is"

Phrase: "more critically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205172:More [Functional Concept]

Phrase: "required for H2O2-induced ASK1 activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C1417014:ASK1 [Gene or Genome]
   753   C1514873:Required [Functional Concept]
   753   C1879547:Activation [Activity]

Phrase: "than TRAF2."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.218: We further examined whether TRAF6 is required for H2O2-induced ASK1 activation in primary cultured cells. 

Phrase: "We further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "is"

Phrase: "required for H2O2-induced ASK1 activation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C1417014:ASK1 [Gene or Genome]
   753   C1514873:Required [Functional Concept]
   753   C1879547:Activation [Activity]

Phrase: "in primary cultured cells."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   901   C0007600:cultured cells [Cell]
   901   C0007635:Cultured Cells [Cell]
   901   C3282338:Cells, Cultured [Cell]
   867 E C0007585:culture cell [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793   C0010453:Culture [Idea or Concept]
   793   C0220814:culture [Functional Concept]
   793   C0430400:Culture [Laboratory Procedure]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   793   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.219: In the macrophages independently prepared from two Traf6-/- mice (30), H2O2-induced activation of ASK1-JNK/p38 pathways were strongly suppressed as was seen in TRAF6-deficient MEFs (Fig. 4E). 

Phrase: "In the macrophages independently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024432:Macrophages [Cell]
   861   C1546706:Macrophages [Intellectual Product]
   861   C1550652:Macrophages [Body Substance]

Phrase: "prepared from two Traf6-/- mice"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0205448:Two [Quantitative Concept]
   760   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1336666:TRAF6 [Gene or Genome]
   726   C1521827:Prepare [Functional Concept]

Phrase: "(30"

Phrase: ")"

Phrase: ","

Phrase: "H2O2-induced activation of ASK1-JNK/p38 pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1879547:Activation [Activity]

Phrase: "were"

Phrase: "strongly"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "as"

Phrase: "was"

Phrase: "seen in TRAF6-deficient MEFs"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   802   C1516828:Mouse Embryonic Fibroblast [Tissue]
   757   C1522260:Mouse Fibroblast [Cell]
   748   C0011155:Deficient [Functional Concept]
   748   C0013935:Embryonic [Embryonic Structure]
   748   C0016030:Fibroblasts [Cell]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0205397:Seen [Qualitative Concept]
   748   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1336666:TRAF6 [Gene or Genome]
   748   C1636779:% deficient [Quantitative Concept]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "(Fig. 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.220: On the other hand, activation of ASK1 by the treatment with thapsigargin, which triggers endoplasmic reticulum stress by depletion of lumenal calcium stores (4), was not impaired in Traf6-/- macrophages (Fig. 4F). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "activation of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1879547:Activation [Activity]

Phrase: "by the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with thapsigargin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "which"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "endoplasmic reticulum stress by depletion of lumenal calcium stores"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   780   C2338598:Lumen of endoplasmic reticulum [Body Space or Junction]
           Endoplasmic reticulum lumen
   764   C0014239:Endoplasmic Reticulum [Cell Component]
   748   C1166837:Endoplasmic reticulum lumen [Cell Component]
   742   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   742   C0038435:Stress [Finding]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impaired in Traf6-/- macrophages"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0024432:Macrophages [Cell]
   770   C0221099:Impaired [Functional Concept]
   770   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0684336:Impaired [Pathologic Function]
   770   C1336666:TRAF6 [Gene or Genome]
   770   C1546706:Macrophages [Intellectual Product]
   770   C1550652:Macrophages [Body Substance]

Phrase: "(Fig. 4F"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450379:4f [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.221: Taken together with our previous finding that TRAF2 and TRAF6 activates ASK1 (5), TRAF2 and TRAF6 appear to be crucial components of the H2O2-induced activation of ASK1. 

Phrase: "Taken together with our previous finding"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0037088:Finding [Sign or Symptom]
   753   C0205156:Previous [Temporal Concept]
   753   C0243095:Finding [Finding]
   753   C1552607:previous [Temporal Concept]
   753   C1883357:Together [Qualitative Concept]
   753   C1883727:Taken [Conceptual Entity]
   753   C2825141:Finding [Finding]
   719 E C1515187:Take [Health Care Activity]

Phrase: "that TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "crucial components of the H2O2-induced activation of ASK1."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0449432:Components [Manufactured Object]
   708 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.222: View larger version (36K): [in this window] [in a new window]  FIGURE 6. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(36K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 6."
Processing 00000000.tx.223: Different susceptibilities of Traf2-/-, Traf5-/-, and Traf6-/- MEFs to H2O2-induced cell death. 

Phrase: "Different susceptibilities of Traf2-/-,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0012655:susceptibilities [Clinical Attribute]
   770   C1264642:susceptibilities [Functional Concept]
   737 E C0220898:Susceptibility [Organism Attribute]
   737 E C1547045:*Susceptibility [Quantitative Concept]

Phrase: "Traf5-/-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "and"

Phrase: "Traf6-/- MEFs to H2O2-induced cell death."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1516828:Mouse Embryonic Fibroblast [Tissue]
   745   C0016030:fibroblast cell [Cell]
           Fibroblasts
   745   C1522260:Mouse Fibroblast [Cell]
Processing 00000000.tx.224: A, trypan blue dye exclusion analysis. 

Phrase: "A,"

Phrase: "trypan blue dye exclusion analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0002778:Analysis [Laboratory Procedure]
   804   C0936012:Analysis [Research Activity]
   804   C1524024:analysis [Functional Concept]
Processing 00000000.tx.225: Wild-type, Traf2-/-, Traf5-/-, and Traf6-/- MEFs were treated with 0.1 mM H2O2 for 10 h. 

Phrase: "Wild-type, Traf2-/-,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0258441:TRAF2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1366777:TRAF2 [Gene or Genome]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "Traf5-/-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "and"

Phrase: "Traf6-/- MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "treated with 0.1 mM H2O2"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   783   C1418486:MM-1 [Gene or Genome]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C1522326:Treated [Functional Concept]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 10 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.226: The cells were stained with 0.4% trypan blue described under "Materials and Methods," washed, and photographed (magnification, 100x). 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with 0.4% trypan blue"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0041213:Trypan blue stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Trypan Blue
   753   C1260957:Blue [Qualitative Concept]
   753   C1565627:Trypan [Organic Chemical]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "described under ""Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: """"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: ","

Phrase: "and"

Phrase: "photographed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0441468:photograph [Manufactured Object]

Phrase: "(magnification,"

Phrase: "100x"

Phrase: ")."
Processing 00000000.tx.227: B, quantitative analysis of H2O2-induced cell death. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "quantitative analysis of H2O2-induced cell death."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0392762:Quantitative [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.228: The percentage of cell death monitored by trypan blue was calculated based on the number of the positive-stained cells in each group. 

Phrase: "The percentage of cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "monitored by trypan blue"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0041213:Trypan Blue [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1260957:Blue [Qualitative Concept]
   770   C1565627:Trypan [Organic Chemical]
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "was"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "based on the number of the positive-stained cells"
Meta Candidates (Total=21; Excluded=7; Pruned=0; Remaining=14)
   762   C0439178:% positive cells [Quantitative Concept]
           % Positive
   745   C0007584:Cell Number [Laboratory Procedure]
   745   C2981742:Base Number [Conceptual Entity]
   742   C0007634:Cells [Cell]
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]
   742   C1446409:Positive [Qualitative Concept]
   742   C1514241:Positive [Finding]
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   742   C2825490:Positive [Qualitative Concept]
   742   C2986582:Stained [Qualitative Concept]
   742   C3282337:Cells [Cell]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1880279:Base [Biomedical or Dental Material]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "in each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.229: At least 200 cells were counted for each group. 

Phrase: "At least 200 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted for each group."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.230: This experiment was performed three times with similar results.  

Phrase: "This experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "three times with similar results."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.231: TRAF6 Is Required for ROS-induced Higher Molecular Mass Complex of ASK1We next examined whether TRAF6-ASK1 interaction can be induced by H2O2. 

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "Is"

Phrase: "Required for ROS-induced Higher Molecular Mass Complex of ASK1We next"
Meta Candidates (Total=20; Excluded=0; Pruned=0; Remaining=20)
   766   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   750   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   749   C0302920:Molecular oxygen [Element, Ion, or Isotope]
   735   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   735   C0205117:next [Spatial Concept]
   735   C0205263:Induced [Functional Concept]
   735   C0205332:Reactive [Qualitative Concept]
   735   C0332282:Next [Temporal Concept]
   735   C0439855:Complex [Qualitative Concept]
   735   C0577559:Mass [Finding]
   735   C1306372:*Mass [Quantitative Concept]
   735   C1514873:Required [Functional Concept]
   735   C1521991:Molecular [Qualitative Concept]
   735   C1704241:Complex [Chemical Viewed Structurally]
   735   C1705920:Species [Conceptual Entity]
   735   C1883708:Next [Temporal Concept]
   702   C0205250:High [Qualitative Concept]
   702   C1299351:High [Qualitative Concept]
   702   C2700149:HIGH [Intellectual Product]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "TRAF6-ASK1 interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "induced by H2O2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.232: Transfected ASK1 was co-immunoprecipitated with TRAF6 in an H2O2-dependent manner, and co-immunoprecipitated ASK1 with TRAF6 was phosphorylated (Fig. 5A). 

Phrase: "Transfected ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417014:ASK1 [Gene or Genome]

Phrase: "was"

Phrase: "co-immunoprecipitated with TRAF6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1336666:TRAF6 [Gene or Genome]
   737   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "in an H2O2-dependent manner,"

Phrase: "and"

Phrase: "co-immunoprecipitated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "ASK1 with TRAF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1417014:ASK1 [Gene or Genome]

Phrase: "was"

Phrase: "phosphorylated"

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.233: H2O2-dependent endogenous interaction of TRAF6 and ASK1 was also readily detectable in HEK293 cells (Fig. 5B). 

Phrase: "H2O2-dependent endogenous interaction of TRAF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "was"

Phrase: "also readily detectable in HEK293 cells"

Phrase: "(Fig. 5B"

Phrase: ")."
Processing 00000000.tx.234: These results suggested that TRAF2 and TRAF6 are likely candidates for the components of H2O2-induced higher molecular mass complex of ASK1. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "are"

Phrase: "likely candidates for the components of H2O2-induced higher molecular mass complex"

Phrase: "of ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.235: To confirm this possibility, MEFs transiently transfected with HA-tagged ASK1WT were treated or untreated with H2O2 and subjected to the gel filtration analysis as determined using HEK293 cells in Fig. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this possibility,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "MEFs transiently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]

Phrase: "transfected with HA-tagged ASK1WT"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   760   C1708632:Tagged [Qualitative Concept]
   726 E C0037293:Tag [Neoplastic Process]
   726 E C0181496:Tag [Manufactured Object]
   726 E C1710492:TAG [Gene or Genome]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "untreated with H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332155:untreated [Finding]

Phrase: "and"

Phrase: "subjected to the gel filtration analysis"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   790   C0008559:Gel Filtration [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0016107:filtration [Laboratory Procedure]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0936012:Analysis [Research Activity]
   753   C1382104:Gel [Substance]
   753   C1524024:analysis [Functional Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "as"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "HEK293 cells in Fig."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C2936239:HEK293 Cells [Cell]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.236: 1C. 

Phrase: "1C."
Processing 00000000.tx.237: Fig. 

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.238: 5C shows that H2O2 induced the shift of ASK1-containing fractions to the higher molecular mass fractions also in MEFs. 

Phrase: "5C"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that H2O2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the shift of ASK1-containing fractions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]

Phrase: "to the higher molecular mass fractions also"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   823   C1264663:*Mass Fraction [Quantitative Concept]
   804   C1264633:Fractions [Quantitative Concept]
   771 E C1554103:Fraction [Idea or Concept]

Phrase: "in MEFs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1516828:Mouse Embryonic Fibroblast [Tissue]
   896   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]
Processing 00000000.tx.239: Immunoblotting analysis of the same membrane with the phospho-ASK1 antibody revealed that H2O2-induced active form of ASK1 was more abundant in the higher molecular mass complex (Fig. 5D, lower panel, lanes 1-4). 

Phrase: "Immunoblotting analysis of the same membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0020985:Immunoblot Analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "with the phospho-ASK1 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that H2O2-induced active form of ASK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "was"

Phrase: "more abundant in the higher molecular mass complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2346714:Abundant [Qualitative Concept]

Phrase: "(Fig. 5D,"

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "lanes 1-4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.240: Furthermore, immunoprecipitation analysis of each fraction revealed that the H2O2-dependent complex formations of TRAF6 and ASK1 were more evident in the higher molecular fractions (fractions 1 and 2) (Fig. 5E). 

Phrase: "Furthermore,"

Phrase: "immunoprecipitation analysis of each fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the H2O2-dependent complex formations of TRAF6"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0439634:Formations [Spatial Concept]
   714 E C0220781:formation [Biologic Function]
   714 E C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "were"

Phrase: "more evident in the higher molecular fractions"

Phrase: "(fractions 1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "(Fig. 5E"

Phrase: ")."
Processing 00000000.tx.241: These results indicate that H2O2-dependent higher molecular mass complex is the active complex of ASK1 and that the recruitment of TRAF6 is responsible at least in part for H2O2-dependent formation of higher molecular mass complex. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that H2O2-dependent higher molecular mass complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "the active complex of ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "that"

Phrase: "the recruitment of TRAF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2949735:Recruitment [Activity]

Phrase: "is"

Phrase: "responsible at least"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "for H2O2-dependent formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "of higher molecular mass complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.242: We have not been successful in detecting TRAF2 in the H2O2-dependent higher molecular mass complex, probably because of the low affinity of TRAF2 antibody or the lesser amount of endogenous TRAF2 compared with TRAF6 in MEFs (data not shown). 

Phrase: "We"

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "successful in detecting TRAF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1272703:Successful [Qualitative Concept]
   703   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "in the H2O2-dependent higher molecular mass complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439855:Complex [Qualitative Concept]
   799   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "probably because of the low affinity of TRAF2 antibody"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   802   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   802   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   750   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   749   C0003255:Antibody Affinity [Molecular Function]
   749   C0034805:antibody receptor [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   735   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   735   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   735   C0205251:low [Qualitative Concept]
   735   C0332281:Associated [Qualitative Concept]
   735   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   735   C0750492:Probably [Idea or Concept]
   735   C1299352:Low [Qualitative Concept]
   735   C1510827:Affinity [Natural Phenomenon or Process]
   735   C1521761:Factor [Functional Concept]
   735   C1550472:low [Idea or Concept]
   735   C2827422:Factor [Conceptual Entity]
   702 E C0750490:Associate [Idea or Concept]
   702 E C1706221:Associate [Professional or Occupational Group]

Phrase: "or"

Phrase: "the lesser amount of endogenous TRAF2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1265611:Amount [Quantitative Concept]

Phrase: "compared with TRAF6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1336666:TRAF6 [Gene or Genome]
   790   C1707455:Compared [Activity]

Phrase: "in MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   988   C1516828:Mouse Embryonic Fibroblast [Tissue]
   896   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblasts [Cell]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.243: To examine the requirement of TRAF6 for H2O2-dependent formation of the higher molecular mass complex, TRAF6-deficient MEFs were analyzed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the requirement of TRAF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "for H2O2-dependent formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "of the higher molecular mass complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "TRAF6-deficient MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   873   C1516828:Mouse Embryonic Fibroblast [Tissue]
   836   C1522260:Mouse Fibroblast [Cell]
   804   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.244: We could not detect H2O2-dependent shift of the ASK1 signalosome in Traf6-/- MEFs (Fig. 5F). 

Phrase: "We"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "H2O2-dependent shift of the ASK1 signalosome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "in Traf6-/- MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]

Phrase: "(Fig. 5F"

Phrase: ")."
Processing 00000000.tx.245: These results suggested that recruitment of TRAF6 is required for H2O2-induced higher molecular mass complex formation of the ASK1 signalosome. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that recruitment of TRAF6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2949735:Recruitment [Activity]

Phrase: "is"

Phrase: "required for H2O2-induced higher molecular mass complex formation"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   764   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   742   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   742   C0205263:Induced [Functional Concept]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C0439855:Complex [Qualitative Concept]
   742   C0577559:Mass [Finding]
   742   C1306372:*Mass [Quantitative Concept]
   742   C1514873:Required [Functional Concept]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1522492:Formation [Functional Concept]
   742   C1704241:Complex [Chemical Viewed Structurally]
   708   C0205250:High [Qualitative Concept]
   708   C1299351:High [Qualitative Concept]
   708   C2700149:HIGH [Intellectual Product]

Phrase: "of the ASK1 signalosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1167160:signalosome [Cell Component]
Processing 00000000.tx.246: Different Susceptibilities of Traf2-/-, Traf5-/-, and Traf6-/- MEFs to H2O2-induced Cell DeathGiven that ASK1 is required for H2O2-induced cell death (8), it is formally possible that TRAF2 and TRAF6 are also involved in such cell death. 

Phrase: "Different Susceptibilities of Traf2-/-,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0012655:susceptibilities [Clinical Attribute]
   770   C1264642:susceptibilities [Functional Concept]
   737 E C0220898:Susceptibility [Organism Attribute]
   737 E C1547045:*Susceptibility [Quantitative Concept]

Phrase: "Traf5-/-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0390681:TRAF5 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420889:TRAF5 [Gene or Genome]

Phrase: "and"

Phrase: "Traf6-/- MEFs to H2O2-induced Cell DeathGiven"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1516828:Mouse Embryonic Fibroblast [Tissue]
   745   C0016030:fibroblast cell [Cell]
           Fibroblasts
   745   C1522260:Mouse Fibroblast [Cell]

Phrase: "that ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "is"

Phrase: "required for H2O2-induced cell death"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0205263:Induced [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1514873:Required [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "formally possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "that TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "are"

Phrase: "also"

Phrase: "involved in such cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1314939:Involved [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.247: We therefore investigated the susceptibility of Traf2-/- and Traf6-/- MEFs to H2O2-induced cell death by trypan blue dye exclusion assay (Fig. 6). 

Phrase: "We therefore"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the susceptibility of Traf2-/-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "and"

Phrase: "Traf6-/- MEFs to H2O2-induced cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   779   C1516828:Mouse Embryonic Fibroblast [Tissue]
   745   C0016030:fibroblast cell [Cell]
           Fibroblasts
   745   C1522260:Mouse Fibroblast [Cell]

Phrase: "by trypan blue dye exclusion assay"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   804   C0243073:assay [Qualitative Concept]
   804   C0680251:EXCLUSION [Functional Concept]
   804   C1510438:Assay [Laboratory Procedure]
   804   C2828389:Exclusion [Activity]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.248: Traf2-/- MEFs were apparently resistant to H2O2-induced cell death as recently reported (38), whereas wild-type and Traf5-/- MEFs were similarly vulnerable to H2O2 treatment. 

Phrase: "Traf2-/- MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "apparently resistant to H2O2-induced cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332325:Resistant to [Functional Concept]
           Resistant
   748   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "as"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(38"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "Traf5-/- MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "similarly vulnerable to H2O2 treatment."
Processing 00000000.tx.249: Traf6-/- MEFs were even more resistant than Traf2-/- MEFs to H2O2-induced cell death, correlating well with the results that H2O2-induced activation of the ASK1-JNK/p38 pathways was more severely impaired in Traf6-/- than Traf2-/- MEFs (Fig. 4, C and D). 

Phrase: "Traf6-/- MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]

Phrase: "were"

Phrase: "even more resistant than Traf2-/- MEFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332325:Resistant [Functional Concept]
   744   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "to H2O2-induced cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "correlating"

Phrase: "well with the results"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205170:Well [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "that H2O2-induced activation of the ASK1-JNK/p38 pathways"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "more severely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205082:Severely [Qualitative Concept]
   861   C0205172:More [Functional Concept]

Phrase: "impaired in Traf6-/-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0221099:Impaired [Functional Concept]
   790   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0684336:Impaired [Pathologic Function]
   790   C1336666:TRAF6 [Gene or Genome]

Phrase: "than Traf2-/- MEFs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C1516828:Mouse Embryonic Fibroblast [Tissue]
   858   C1522260:Mouse Fibroblast [Cell]
   812   C0016030:Fibroblasts [Cell]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.250: These results demonstrated that TRAF2 and TRAF6 are novel components of the ROS-induced ASK1 signaling pathway and play an essential role in ROS-induced cell death.  

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrated"

Phrase: "that TRAF2"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "are"

Phrase: "novel components of the ROS-induced ASK1 signaling pathway"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C0449432:Components [Manufactured Object]
   704 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an essential role in ROS-induced cell death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.251: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The importance of the so called signalosome has been emerging, in that cells may take advantage of the preformed multi-molecular complex to commence rapid as well as specific signaling events in response to the cellular input. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The importance of the so called signalosome"

Phrase: "has"

Phrase: "been"

Phrase: "emerging,"

Phrase: "in that cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "take"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515187:Take [Health Care Activity]

Phrase: "advantage of the preformed multi-molecular complex to"

Phrase: "commence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3274784:Commence [Activity]

Phrase: "rapid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439831:Rapid [Qualitative Concept]

Phrase: "as well as"

Phrase: "specific signaling events in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441471:Events [Event]
   760   C3541888:Events [Classification]

Phrase: "to the cellular input."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708517:Input [Conceptual Entity]
Processing 00000000.tx.252: For example, the IB kinase (IKKs) complex, a signalosome composed of IKK, IKK, and NEMO (IKK), forms an HMM complex and plays an essential role in NF-B activation (40-45). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the IB kinase (IKKs) complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "a signalosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1167160:signalosome [Cell Component]

Phrase: "composed of IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1150571:IKK [Molecular Function]

Phrase: "IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "and"

Phrase: "NEMO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416380:NEMO [Gene or Genome]
  1000   C2697645:NEMO [Gene or Genome]
  1000   C2698408:NEMO [Amino Acid, Peptide, or Protein]

Phrase: "(IKK"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: ")"

Phrase: ","

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "an HMM complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an essential role in NF-B activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "(40-45"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.253: Activations of certain caspases were also reported to require HMM complex formation, such as apoptosome for caspase-9 (37, 46) and inflammasome for caspase-1 and -5 (47-49). 

Phrase: "Activations of certain caspases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   786   C1159825:Caspase Activation [Molecular Function]
   737   C1879547:Activation [Activity]

Phrase: "were"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "require"

Phrase: "HMM complex formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "such as apoptosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1657248:Apoptosome [Cell Component]

Phrase: "for caspase-9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(37,"

Phrase: "46"

Phrase: ")"

Phrase: "and"

Phrase: "inflammasome for caspase-1"

Phrase: "and -"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(47-49"

Phrase: ")."
Processing 00000000.tx.254: Apaf-1 and NALP1, the members of the nucleotide binding-site family, are the specific components to assemble large caspase complexes for apoptosome and inflammasome, respectively. 

Phrase: "Apaf-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0664613:Apaf-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332098:APAF-1 [Gene or Genome]

Phrase: "and"

Phrase: "NALP1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1826435:NALP1 [Gene or Genome]
  1000   C3538756:NALP1 [Gene or Genome]

Phrase: "the members of the nucleotide binding-site family,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   767   C0086282:Family Members [Family Group]
   750 E C1611821:Family Member [Intellectual Product]
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "are"

Phrase: "the specific components to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0449432:Components [Manufactured Object]
   737 E C1705248:Component [Conceptual Entity]

Phrase: "assemble"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706853:Assemble [Activity]

Phrase: "large caspase complexes for apoptosome"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1704241:Complexes [Chemical Viewed Structurally]
   726 E C0439855:Complex [Qualitative Concept]

Phrase: "and"

Phrase: "inflammasome,"

Phrase: "respectively."
Processing 00000000.tx.255: Apoptosome, for example, which is formed by the recruitment of caspase-9 to Apaf-1, brings several caspase-9 molecules into close proximity, resulting in their efficient cross-activation (37, 46). 

Phrase: "Apoptosome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1657248:Apoptosome [Cell Component]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "which"

Phrase: "is"

Phrase: "formed by the recruitment of caspase-9"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0205431:Formed [Functional Concept]
   748   C2949735:Recruitment [Activity]
   714 E C0348078:Form [Qualitative Concept]
   714 E C0376315:Form [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "to Apaf-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0664613:Apaf-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332098:APAF-1 [Gene or Genome]

Phrase: "brings"

Phrase: "several caspase-9 molecules into close proximity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:molecules [Substance]

Phrase: "resulting in their efficient cross-activation"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0332294:Resulting in [Functional Concept]
   753   C0442799:Efficient [Qualitative Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1879547:Activation [Activity]
   753   C2828360:Cross [Conceptual Entity]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "(37,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.256: These findings validate the comprehensive analysis of ASK1 signalosome to understand the ASK1-dependent signaling mechanisms of oxidative stress-induced cell death. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "validate"

Phrase: "the comprehensive analysis of ASK1 signalosome to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "understand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understand [Mental Process]

Phrase: "the ASK1-dependent signaling mechanisms of oxidative stress-induced cell death."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1708951:Mechanism of Cell Death [Cell Function]
   738   C0441712:Mechanisms [Functional Concept]
   704 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.257: In the present study, we found that ASK1 forms a static HMM complex composed of homo-oligomeric ASK1, Trx, and yet unidentified component(s) in unstimulated cells. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a static HMM complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0439855:Complex [Qualitative Concept]
   804   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "composed of homo-oligomeric ASK1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1300203:Homo [Mammal]
   760   C1417014:ASK1 [Gene or Genome]
   760   C3245470:HOMO [Finding]

Phrase: "Trx,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "and"

Phrase: "yet unidentified component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449432:Component [Manufactured Object]
   827   C1705248:Component [Conceptual Entity]

Phrase: "("

Phrase: "s) in unstimulated cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0439819:Unstimulated [Qualitative Concept]
   770   C2603362:S' [Clinical Attribute]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.258: We also found that oxidative stress-dependent dissociation of Trx and reciprocal recruitment of TRAF2 and TARF6 to the ASK1 signaling complex are required for the activation of ASK1. 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that oxidative stress-dependent dissociation of Trx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "reciprocal recruitment of TRAF2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C2949735:Recruitment [Activity]
   703   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "and"

Phrase: "TARF6 to the ASK1 signaling complex"

Phrase: "are"

Phrase: "required for the activation of ASK1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1417014:ASK1 [Gene or Genome]
   753   C1514873:Required [Functional Concept]
   753   C1879547:Activation [Activity]
Processing 00000000.tx.259: Because H2O2-induced activation of ASK1 was almost completely abolished in Traf6-/- cells (Fig. 4, B and E), TRAF6 appears to be the most important among TRAF family proteins for the activation of ASK1. 

Phrase: "Because"

Phrase: "H2O2-induced activation of ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "was"

Phrase: "almost completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "abolished in Traf6-/- cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1336666:TRAF6 [Gene or Genome]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "E"

Phrase: ")"

Phrase: ","

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "the most important among TRAF family proteins"

Phrase: "for the activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.260: However, how TRAFs mechanistically contribute to the activation of ASK1 is yet to be elucidated. 

Phrase: "However,"

Phrase: "how TRAFs mechanistically"

Phrase: "contribute to the activation of ASK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1417014:ASK1 [Gene or Genome]
   753   C1879547:Activation [Activity]
   753   C1880177:Contribute [Activity]

Phrase: "is"

Phrase: "yet to"

Phrase: "be"

Phrase: "elucidated."
Processing 00000000.tx.261: In this regard, two possibilities, physical and/or chemical modifications of ASK1, might apply. 

Phrase: "In this regard,"

Phrase: "two possibilities,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   777   C0332149:Possible [Qualitative Concept]
   777   C1705910:Possible [Qualitative Concept]
   777   C2362652:Possible [Qualitative Concept]

Phrase: "physical"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0031809:Physical [Health Care Activity]
  1000   C0205485:Physical [Functional Concept]
  1000   C1509143:Physical [Finding]

Phrase: "and/or"

Phrase: "chemical modifications of ASK1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0392747:Modification [Functional Concept]
   737   C1554963:modification [Qualitative Concept]

Phrase: "might"

Phrase: "apply."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]
Processing 00000000.tx.262: Because TRAF family proteins appear to form trimers in vivo (50-52), physical association of TRAF6 may facilitate multimeric complex formation, resulting in close proximity of ASK1 molecules and thereby autophosphorylation-dependent activation. 

Phrase: "Because"

Phrase: "TRAF family proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1449799:TRAF Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "trimers"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(50-52"

Phrase: ")"

Phrase: ","

Phrase: "physical association of TRAF6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "may"

Phrase: "facilitate"

Phrase: "multimeric complex formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "resulting in close proximity of ASK1 molecules"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   778   C0332294:Resulting in [Functional Concept]
   748   C0567416:molecules [Substance]
   748   C0587267:Close [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   748   C1417014:ASK1 [Gene or Genome]
   748   C1514583:Proximity [Spatial Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "thereby autophosphorylation-dependent activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1879547:Activation [Activity]
Processing 00000000.tx.263: Although ASK1coil, a deletion mutant of the C-terminal oligomerization domain, exhibited very low kinase activity (Fig. 1A), it was shown that forced homo-oligomerization of ASK1coil by chemical oligomerizer induced kinase activation of this mutant (11), suggesting that a close proximity of ASK1 molecules is sufficient to activate ASK1. 

Phrase: "Although"

Phrase: "ASK1coil,"

Phrase: "a deletion mutant of the C-terminal oligomerization domain,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "very low kinase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1150423:kinase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that forced homo-oligomerization of ASK1coil"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1300203:Homo [Mammal]
   753   C3245470:HOMO [Finding]

Phrase: "by chemical oligomerizer induced kinase activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1879547:Activation [Activity]

Phrase: "of this mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a close proximity of ASK1 molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514583:Proximity [Spatial Concept]

Phrase: "is"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.264: Nevertheless, the endogenous ASK1 signaling complex appears to be present as a homo-oligomerized but still inactive form (Fig. 2). 

Phrase: "Nevertheless,"

Phrase: "the endogenous ASK1 signaling complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present as a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "homo-oligomerized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "but"

Phrase: "still inactive form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0348078:Form [Qualitative Concept]
   827   C0376315:Form [Manufactured Object]
   827   C1522492:Form [Functional Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.265: These findings suggest that the homooligomerization of ASK1 through the C-terminal coiled-coil domain is not sufficient for ASK1 activation. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the homooligomerization of ASK1"

Phrase: "through the C-terminal coiled-coil domain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C1516692:Coiled-Coil Domain [Amino Acid Sequence]
   804   C1880389:Domain [Functional Concept]
   804   C1883221:Domain [Conceptual Entity]
   804   C3541951:Domain [Intellectual Product]

Phrase: "is"

Phrase: "not sufficient for ASK1 activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.266: Thus, the endogenously homo-oligomerized ASK1 is likely to be kept inactive by the presence of Trx, a "safety lock" for ASK1. 

Phrase: "Thus,"

Phrase: "the endogenously"

Phrase: "homo-oligomerized"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300203:Homo [Mammal]
   861   C3245470:HOMO [Finding]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "kept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "inactive by the presence of Trx,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205254:Inactive [Qualitative Concept]

Phrase: "a ""safety lock"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1550024:Lock [Idea or Concept]
   827   C1704783:Lock [Manufactured Object]

Phrase: "for ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.267: Dissociation of Trx from ASK1 signaling complex appears to allow the association of TRAF2 and TRAF6 to ASK1 and thereby induce the close proximity-dependent conformational changes in the interface of the kinase domain of ASK1. 

Phrase: "Dissociation of Trx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "from ASK1 signaling complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "the association of TRAF2"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0004083:Association [Mental Process]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0699792:association [Social Behavior]
   703   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "and"

Phrase: "TRAF6 to ASK1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1336666:TRAF6 [Gene or Genome]

Phrase: "and"

Phrase: "thereby"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the close proximity-dependent conformational changes in the interface of the kinase domain"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   735   C0392747:changes [Functional Concept]
   735   C0443172:changes [Quantitative Concept]
   733   C0301641:Conformational change [Molecular Function]
   732   C0025320:The change [Physiologic Function]
   702 E C1705241:Change [Quantitative Concept]

Phrase: "of ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.268: The tight oligomerization assisted by the associated molecules may be physiologically necessary and sufficient for the autophosphorylation-dependent activation of ASK1. 

Phrase: "The tight oligomerization"

Phrase: "assisted by the associated molecules"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0332281:Associated [Qualitative Concept]
   760   C0567416:molecules [Substance]
   760   C1269765:Assisted [Finding]
   726 E C0018896:assist [Social Behavior]
   726 E C0557034:assist [Health Care Activity]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "may"

Phrase: "be"

Phrase: "physiologically necessary"

Phrase: "and"

Phrase: "sufficient for the autophosphorylation-dependent activation of ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205410:Sufficient [Qualitative Concept]
Processing 00000000.tx.269: Activation status of the ASK1 signaling complex in oxidative stress response may thus be switched by reciprocal changes in the components of the signalosome; 

Phrase: "Activation status of the ASK1 signaling complex"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449438:Status [Qualitative Concept]

Phrase: "in oxidative stress response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0149784:stress response [Physiologic Function]
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "thus"

Phrase: "be"

Phrase: "switched by reciprocal changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1882911:Reciprocal [Qualitative Concept]
   737 E C1705241:Change [Quantitative Concept]
   737   C1707719:Switch [Manufactured Object]

Phrase: "in the components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "of the signalosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1167160:signalosome [Cell Component]

Phrase: ";"
Processing 00000000.tx.270: from ASK1-Trx signaling complex (inactive form) to the ASK1-TRAF2/TRAF6 signaling complex (active form) (Fig. 7). 

Phrase: "from ASK1-Trx signaling complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439855:Complex [Qualitative Concept]
   812   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(inactive form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: "to the ASK1-TRAF2/TRAF6 signaling complex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   866   C1523873:receptor complex [Cell Component]
   791   C0439855:Complex [Qualitative Concept]
   791   C1704241:Complex [Chemical Viewed Structurally]
   707   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   707   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "(active form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0348078:Form [Qualitative Concept]
   861   C0376315:Form [Manufactured Object]
   861   C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.271: View larger version (28K): [in this window] [in a new window]  FIGURE 7. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIGURE 7."
Processing 00000000.tx.272: A schematic model of ROS-induced active configuration of the ASK1 signalosome. 

Phrase: "A schematic model of ROS-induced active configuration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C3161035:Model [Intellectual Product]

Phrase: "of the ASK1 signalosome."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1167160:signalosome [Cell Component]
Processing 00000000.tx.273: See "Discussion" for details.  

Phrase: "See ""Discussion"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: "for details."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522508:Details [Qualitative Concept]
   966 E C1561567:detail [Functional Concept]
Processing 00000000.tx.274: Another possible mechanism by which TRAFs activate ASK1 may include chemical modifications, such as ubiquitination. 

Phrase: "Another possible mechanism by which TRAFs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "may"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "chemical modifications,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "such as ubiquitination."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519751:Ubiquitination [Molecular Function]
Processing 00000000.tx.275: TRAF6 is a RING domain-containing ubiquitin ligase that synthesizes Lys63-linked polyubiquitin chains (53). 

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "is"

Phrase: "a RING domain-containing ubiquitin ligase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0023689:Ligase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "synthesizes"

Phrase: "Lys63-linked polyubiquitin chains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0337112:chains [Manufactured Object]
   812   C1524075:Chains [Idea or Concept]

Phrase: "(53"

Phrase: ")."
Processing 00000000.tx.276: The targets of Lys63-linked polyubiquitination include NEMO, TRAF2, and TRAF6 itself, and the ubiquitinated TRAF6 is implicated in the activation of downstream effectors such as NEMO and TAK1 (54, 55). 

Phrase: "The targets of Lys63-linked polyubiquitination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1521840:Target [Functional Concept]
   719   C2986546:TARGET [Diagnostic Procedure]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "NEMO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416380:NEMO [Gene or Genome]
  1000   C2697645:NEMO [Gene or Genome]
  1000   C2698408:NEMO [Amino Acid, Peptide, or Protein]

Phrase: "TRAF2,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   840   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0332281:Associated [Qualitative Concept]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   771 E C0750490:Associate [Idea or Concept]
   771 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1336666:TRAF6 [Gene or Genome]

Phrase: "itself,"

Phrase: "and"

Phrase: "the ubiquitinated TRAF6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1336666:TRAF6 [Gene or Genome]

Phrase: "is"

Phrase: "implicated in the activation of downstream effectors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0522506:Downstream [Spatial Concept]
   748   C1879547:Activation [Activity]

Phrase: "such as NEMO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1416380:NEMO [Gene or Genome]
  1000   C2697645:NEMO [Gene or Genome]
  1000   C2698408:NEMO [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "TAK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1334477:TAK1 [Gene or Genome]
  1000   C1417830:TAK1 [Gene or Genome]
  1000   C1708802:TAK1 [Gene or Genome]

Phrase: "(54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.277: Similar implications of TRAF2 are also reported (56, 57). 

Phrase: "Similar implications of TRAF2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   703   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   703   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]

Phrase: "are"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(56,"

Phrase: "57"

Phrase: ")."
Processing 00000000.tx.278: It was also reported that RIP1 is ubiquitinated by TRAF2 in a TNF-dependent manner, which induces the activation of NF-B and p38 MAP kinase (58). 

Phrase: "It"

Phrase: "was"

Phrase: "also"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that RIP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539807:RIP1 [Gene or Genome]

Phrase: "is"

Phrase: "ubiquitinated by TRAF2"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   897   C0258441:TNF receptor-associated factor 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C1366777:TNF RECEPTOR-ASSOCIATED FACTOR 2 [Gene or Genome]
   778   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C0041538:Ubiquitinated [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332281:Associated [Qualitative Concept]
   748   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in a TNF-dependent manner,"

Phrase: "which"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the activation of NF-B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "p38 MAP kinase"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1456380:p38 Mitogen Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   979 E C1120843:p38 Mitogen-Activated Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           p38 Protein Kinase
   937   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   884   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0026249:Mitogen [Pharmacologic Substance]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1879547:Activated [Activity]
   771 E C1515877:Activate [Functional Concept]

Phrase: "(58"

Phrase: ")."
Processing 00000000.tx.279: Although the role of Lys63-linked polyubiquitination remains unclear, ASK1 might require the Lys63-linked polyubiquitination by TRAF2 or TRAF6 for the kinase activation. 

Phrase: "Although"

Phrase: "the role of Lys63-linked polyubiquitination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "remains"

Phrase: "unclear, ASK1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417014:ASK1 [Gene or Genome]

Phrase: "might"

Phrase: "require"

Phrase: "the Lys63-linked polyubiquitination by TRAF2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1514216:Polyubiquitination [Molecular Function]

Phrase: "or"

Phrase: "TRAF6 for the kinase activation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0530129:TRAF6 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1336666:TRAF6 [Gene or Genome]
Processing 00000000.tx.280: Thus, further studies are required for the elucidation of mechanisms by which the TRAF family proteins activate ASK1. 

Phrase: "Thus,"

Phrase: "further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "required for the elucidation of mechanisms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0441712:Mechanisms [Functional Concept]
   753   C1514873:Required [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "by which"

Phrase: "the TRAF family proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C1449799:TRAF Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "ASK1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]
Processing 00000000.tx.281: Uncovering the unidentified components in the ASK1 signaling complex may reveal precise mechanisms of the ASK1-dependent signaling cascade that links oxidative stress and cell death.  

Phrase: "Uncovering"

Phrase: "the unidentified components in the ASK1 signaling complex"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0449432:Components [Manufactured Object]
   711 E C1705248:Component [Conceptual Entity]

Phrase: "may"

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "precise mechanisms of the ASK1-dependent signaling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441712:Mechanisms [Functional Concept]
   714 E C1706376:Mechanism [Manufactured Object]

Phrase: "cascade"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707310:Cascade [Manufactured Object]

Phrase: "that"

Phrase: "links"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.282: FOOTNOTES  * This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, by CREST, Japan Science and Technology Corporation, and by Center of Excellence Program. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants-in-aid"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0018173:Grants [Quantitative Concept]
   760   C0018896:Aid [Social Behavior]
   760   C0449435:Aid [Manufactured Object]
   760   C1521721:Supported [Conceptual Entity]
   760   C3540469:AID [Gene or Genome]
   726 E C0183683:Support [Medical Device]
   726 E C1548284:Grant [Idea or Concept]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "from the Ministry"

Phrase: "of Education,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0013621:Education [Educational Activity]
  1000   C0013622:education [Classification]
  1000   C0013658:Education, NOS [Finding]
  1000   C0039401:Education [Educational Activity]
   928 E C1555905:Educational [Intellectual Product]

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Culture of Japan,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0010453:Culture [Idea or Concept]
   790   C0220814:culture [Functional Concept]
   790   C0430400:Culture [Laboratory Procedure]
   790   C2242979:Culture [Laboratory Procedure]

Phrase: "by CREST,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0332243:crest [Functional Concept]
  1000   C1947915:Crest [Spatial Concept]
  1000   C2948667:Crest [Pharmacologic Substance]
   907 E C0229465:cristae [Body Part, Organ, or Organ Component]
   907 E C0230844:cristae [Cell Component]

Phrase: "Japan Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "and by Center of Excellence Program."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205099:Center [Spatial Concept]
   753   C1515981:And [Idea or Concept]
   753   C1709697:Program [Conceptual Entity]
   753   C2728259:Program [Pharmacologic Substance]
   753   C3484370:Program [Functional Concept]
Processing 00000000.tx.283: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.284: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.285: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.286: 1 To whom correspondence should be addressed: Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. 

Phrase: "1 To whom correspondence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0282413:Correspondence [Intellectual Product]
   770   C2827734:1+ [Quantitative Concept]
   770   C2981698:1+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "Laboratory of Cell Signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "The University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "7-3-1 Hongo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0720890:hongo [Organic Chemical,Pharmacologic Substance]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo 113-0033,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.287: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.288: 81-5841-4859; 

Phrase: "81-5841-4859"

Phrase: ";"
Processing 00000000.tx.289: Fax: 81-5841-4778; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "81-5841-4778"

Phrase: ";"
Processing 00000000.tx.290: E-mail: ichijo{at}mol.f.u-tokyo.ac.jp . 2 The abbreviations used are: ASK1, apoptosis signal-regulating kinase 1; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ichijo{at}mol.f.u-tokyo.ac.jp . 2"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   807   C1422483:JP-2 [Gene or Genome]
   791   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   791   C0027960:Mole [Neoplastic Process]
   791   C0040371:Tokyo [Geographic Area]
   791   C0324740:Mole [Mammal]
   791   C0439133:(f) [Intellectual Product]
   791   C0439189:Mole [Quantitative Concept]
   791   C1412573:AC [Gene or Genome]
   791   C1456781:mole [Neoplastic Process]
   791   C1553038:[f] [Quantitative Concept]
   791   C1824986:mol [Gene or Genome]
   791   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   791   C3539770:AC [Gene or Genome]
   708 E C0026367:Molar [Body Part, Organ, or Organ Component]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "ASK1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417014:ASK1 [Gene or Genome]

Phrase: "apoptosis signal-regulating kinase 1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0532128:Apoptosis Signal-Regulating Kinase 1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1417014:APOPTOSIS SIGNAL-REGULATING KINASE 1 [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0162638:Apoptosis [Cell Function]
   804   C1710082:Signal [Phenomenon or Process]
   733 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.291: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.292: TNF, tumor necrosis factor; 

Phrase: "TNF,"

Phrase: "tumor necrosis factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: ";"
Processing 00000000.tx.293: TRAF, TNF receptor-associated factor; 

Phrase: "TRAF,"

Phrase: "TNF receptor-associated factor"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0077503:TNF Receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C0332281:Associated [Qualitative Concept]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: ";"
Processing 00000000.tx.294: MAP, mitogen-activated protein; 

Phrase: "MAP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "mitogen-activated protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.295: MAPKKK, MAP kinase kinase kinase; 

Phrase: "MAPKKK,"

Phrase: "MAP kinase kinase kinase"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   972   C0211705:Mitogen-Activated Protein Kinase Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   905   C0169101:Mitogen-Activated Protein Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0752312:Mitogen-Activated Protein Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1979930:Mitogen-activated protein [Amino Acid, Peptide, or Protein]
   827   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0018284:Mitogen [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0026249:Mitogen [Pharmacologic Substance]
   799   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1879547:Activated [Activity]
   766 E C1515877:Activate [Functional Concept]

Phrase: ";"
Processing 00000000.tx.296: JNK, c-Jun N-terminal kinase; 

Phrase: "JNK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150587:JNK [Molecular Function]
  1000   C1367731:JNK [Gene or Genome]
  1000   C1705632:JNK [Gene or Genome]

Phrase: "c-Jun N-terminal kinase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
  1000   C0248813:c-jun N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0380051:c-JUN N-Terminal Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   937   C1367731:JUN N-terminal kinase [Gene or Genome]
   911   C0872123:c JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0872053:JUN kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1334482:Jun kinase [Gene or Genome]
   875   C1367019:Jun Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   875   C1707271:C-Terminal [Amino Acid Sequence]
   840   C0162508:c-Jun [Gene or Genome]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205088:Terminal [Temporal Concept]
   804   C1553033:[c] [Quantitative Concept]
   804   C1705314:Terminal [Manufactured Object]
   804   C1705315:Terminal [Spatial Concept]
   804   C3536909:JUN [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.297: Trx, thioredoxin; 

Phrase: "Trx,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "thioredoxin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0039938:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1504637:Thioredoxin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1514764:Thioredoxin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C3496084:Thioredoxin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.298: MEKK, MAP kinase/extracellular signal-regulated kinase kinase kinase; 

Phrase: "MEKK,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1150582:MEKK [Molecular Function]
  1000   C1367675:MEKK [Gene or Genome]
  1000   C1708800:MEKK [Gene or Genome]

Phrase: "MAP kinase/extracellular signal-regulated kinase kinase kinase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   705   C0211705:Mitogen-Activated Protein Kinase Kinase Kinases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.299: MEF, mouse embryonic fibroblast; 

Phrase: "MEF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0280603:MeF [Therapeutic or Preventive Procedure]
  1000   C1414377:MEF [Gene or Genome]
  1000   C3273431:MEF [Gene or Genome]

Phrase: "mouse embryonic fibroblast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1516828:Mouse Embryonic Fibroblast [Tissue]
   913   C1522260:Mouse Fibroblast [Cell]
   827   C0016030:Fibroblast [Cell]

Phrase: ";"
Processing 00000000.tx.300: HA, hemagglutinin; 

Phrase: "HA,"

Phrase: "hemagglutinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018909:Haemagglutinin, NOS [Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.301: Chaps, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid; 

Phrase: "Chaps,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0047101:CHAPS [Pharmacologic Substance,Steroid]
   966 E C0950540:chap [Therapeutic or Preventive Procedure]

Phrase: "3-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "["

Phrase: "(3-cholamidopropyl"

Phrase: ")"

Phrase: "dimethylammonio"

Phrase: "]-1-propanesulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.302: HMM, high molecular mass; 

Phrase: "HMM,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "high molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.303: IKK, IB kinase.  

Phrase: "IKK,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0663914:IKK [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1150571:IKK [Molecular Function]

Phrase: "IB kinase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.304: ACKNOWLEDGMENTS  We gratefully acknowledge Tak W. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We gratefully"

Phrase: "acknowledge"

Phrase: "Tak W."
Processing 00000000.tx.305: Mak and Wen-Chen Yeh for providing Traf2-/- MEFs. 

Phrase: "Mak"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416988:MAK [Gene or Genome]
  1000   C1538267:MAK [Gene or Genome]

Phrase: "and"

Phrase: "Wen-Chen Yeh for providing Traf2-/- MEFs."
Processing 00000000.tx.306: We also thank all members of the Cell Signaling Laboratory for helpful discussions.  

Phrase: "We also"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "all members of the Cell Signaling Laboratory"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "for helpful discussions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0557061:discussions [Therapeutic or Preventive Procedure]
   827 E C2584313:Discussion [Social Behavior]
Processing 00000000.tx.307: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Takeda, K., Matsuzawa, A., Nishitoh, H., and Ichijo, H. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsuzawa,"

Phrase: "A.,"

Phrase: "Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.308: (2003) Cell Struct. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Cell Struct."
Processing 00000000.tx.309: Funct. 

Phrase: "Funct."
Processing 00000000.tx.310: 28, 23-29[CrossRef][Medline] [OrderarticleviaInfotrieve] Ichijo, H., Nishida, E., Irie, K., ten Dijke, P., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., and Gotoh, Y. 

Phrase: "28,"

Phrase: "23-29"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450348:23 [Quantitative Concept]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ichijo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nishida,"

Phrase: "E.,"

Phrase: "Irie,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "ten Dijke,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014518:TEN [Disease or Syndrome]
   861   C0205456:Ten [Quantitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Saitoh,"

Phrase: "M."

Phrase: ","

Phrase: "Moriguchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takagi,"

Phrase: "M."

Phrase: ","

Phrase: "Matsumoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Miyazono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Gotoh,"

Phrase: "Y."
Processing 00000000.tx.311: (1997) Science 275, 90-94[Abstract/Free FullText] Matsukawa, J., Matsuzawa, A., Takeda, K., and Ichijo, H. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 275,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "90-94"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "[Abstract/Free FullText"

Phrase: "] Matsukawa,"

Phrase: "J.,"

Phrase: "Matsuzawa,"

Phrase: "A.,"

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.312: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.313: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.314: (Tokyo) 136, 261-265[Abstract/Free FullText] Nishitoh, H., Matsuzawa, A., Tobiume, K., Saegusa, K., Takeda, K., Inoue, K., Hori, S., Kakizuka, A., and Ichijo, H. 

Phrase: "(Tokyo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: ")"

Phrase: "136,"

Phrase: "261-265"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsuzawa,"

Phrase: "A.,"

Phrase: "Tobiume,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saegusa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Inoue,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hori,"

Phrase: "S."

Phrase: ","

Phrase: "Kakizuka,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.315: (2002) Genes Dev. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.316: 16, 1345-1355[Abstract/Free FullText] Nishitoh, H., Saitoh, M., Mochida, Y., Takeda, K., Nakano, H., Rothe, M., Miyazono, K., and Ichijo, H. 

Phrase: "16,"

Phrase: "1345-1355"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Saitoh,"

Phrase: "M."

Phrase: ","

Phrase: "Mochida,"

Phrase: "Y.,"

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nakano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rothe,"

Phrase: "M."

Phrase: ","

Phrase: "Miyazono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.317: (1998) Mol. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.318: Cell 2, 389-395[CrossRef][Medline] [OrderarticleviaInfotrieve] Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. 

Phrase: "Cell 2,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "389-395"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Saitoh,"

Phrase: "M."

Phrase: ","

Phrase: "Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Fujii,"

Phrase: "M."

Phrase: ","

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tobiume,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Sawada,"

Phrase: "Y.,"

Phrase: "Kawabata,"

Phrase: "M."

Phrase: ","

Phrase: "Miyazono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.319: (1998) EMBO J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.320: 17, 2596-2606[Abstract/Free FullText] Takeda, K., Matsuzawa, A., Nishitoh, H., Tobiume, K., Kishida, S., Ninomiya-Tsuji, J., Matsumoto, K., and Ichijo, H. 

Phrase: "17,"

Phrase: "2596-2606"

Phrase: "[Abstract/Free FullText"

Phrase: "] Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsuzawa,"

Phrase: "A.,"

Phrase: "Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tobiume,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Kishida,"

Phrase: "S."

Phrase: ","

Phrase: "Ninomiya-Tsuji,"

Phrase: "J.,"

Phrase: "Matsumoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.321: (2004) EMBO Rep. 

Phrase: "(2004"

Phrase: ")"

Phrase: "EMBO Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.322: 5, 161-166[Abstract/Free FullText] Tobiume, K., Matsuzawa, A., Takahashi, T., Nishitoh, H., Morita, K., Takeda, K., Minowa, O., Miyazono, K., Noda, T., and Ichijo, H. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "161-166"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tobiume,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsuzawa,"

Phrase: "A.,"

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Morita,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Minowa,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Miyazono,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Noda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.323: (2001) EMBO Rep. 

Phrase: "(2001"

Phrase: ")"

Phrase: "EMBO Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.324: 2, 222-228[Abstract/Free FullText] Liu, Y., and Min, W. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "222-228"

Phrase: "[Abstract/Free FullText"

Phrase: "] Liu,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "W."
Processing 00000000.tx.325: (2002) Circ. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Circ."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332520:Circ [Quantitative Concept]
  1000   C2347774:circ [Quantitative Concept]
Processing 00000000.tx.326: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.327: 90, 1259-1266[Abstract/Free FullText] Gotoh, Y., and Cooper, J. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "1259-1266"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gotoh,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.328: A. 

Phrase: "A."
Processing 00000000.tx.329: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.330: Biol. 

Phrase: "Biol."
Processing 00000000.tx.331: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.332: 273, 17477-17482[Abstract/Free FullText] Tobiume, K., Saitoh, M., and Ichijo, H. 

Phrase: "273,"

Phrase: "17477-17482"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tobiume,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Saitoh,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.333: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.334: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.335: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.336: 191, 95-104[CrossRef][Medline] [OrderarticleviaInfotrieve] Chen, G., and Goeddel, D. 

Phrase: "191,"

Phrase: "95-104"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goeddel,"

Phrase: "D."
Processing 00000000.tx.337: V. 

Phrase: "V."
Processing 00000000.tx.338: (2002) Science 296, 1634-1635[Abstract/Free FullText] Devin, A., Cook, A., Lin, Y., Rodriguez, Y., Kelliher, M., and Liu, Z. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Science 296,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1634-1635"

Phrase: "[Abstract/Free FullText"

Phrase: "] Devin,"

Phrase: "A.,"

Phrase: "Cook,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0335326:Cook [Daily or Recreational Activity]
  1000   C1306756:Cook [Professional or Occupational Group]

Phrase: "A.,"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Y.,"

Phrase: "Rodriguez,"

Phrase: "Y.,"

Phrase: "Kelliher,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Liu,"

Phrase: "Z."
Processing 00000000.tx.339: (2000) Immunity 12, 419-429[CrossRef][Medline] [OrderarticleviaInfotrieve] Hsu, H., Shu, H. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Immunity 12,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: "419-429"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hsu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.340: B., Pan, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085999:Pan [Mammal]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.341: G., and Goeddel, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goeddel,"

Phrase: "D."
Processing 00000000.tx.342: V. 

Phrase: "V."
Processing 00000000.tx.343: (1996) Cell 84, 299-308[CrossRef][Medline] [OrderarticleviaInfotrieve] Liu, Z. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 84,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "299-308"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Liu,"

Phrase: "Z."
Processing 00000000.tx.344: G., Hsu, H., Goeddel, D. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hsu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Goeddel,"

Phrase: "D."
Processing 00000000.tx.345: V., and Karin, M. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.346: (1996) Cell 87, 565-576[CrossRef][Medline] [OrderarticleviaInfotrieve] Rothe, M., Sarma, V., Dixit, V. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Cell 87,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "565-576"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rothe,"

Phrase: "M."

Phrase: ","

Phrase: "Sarma,"

Phrase: "V.,"

Phrase: "Dixit,"

Phrase: "V."
Processing 00000000.tx.347: M., and Goeddel, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Goeddel,"

Phrase: "D."
Processing 00000000.tx.348: V. 

Phrase: "V."
Processing 00000000.tx.349: (1995) Science 269, 1424-1427[Medline] [OrderarticleviaInfotrieve] Liu, H., Nishitoh, H., Ichijo, H., and Kyriakis, J. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Science 269,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1424-1427"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Liu,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ichijo,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kyriakis,"

Phrase: "J."
Processing 00000000.tx.350: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.351: (2000) Mol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.352: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.353: Biol. 

Phrase: "Biol."
Processing 00000000.tx.354: 20, 2198-2208[Abstract/Free FullText] Baud, V., Liu, Z. 

Phrase: "20,"

Phrase: "2198-2208"

Phrase: "[Abstract/Free FullText"

Phrase: "] Baud,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553021:baud [Quantitative Concept]

Phrase: "V.,"

Phrase: "Liu,"

Phrase: "Z."
Processing 00000000.tx.355: G., Bennett, B., Suzuki, N., Xia, Y., and Karin, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Bennett,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.356: (1999) Genes Dev. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.357: 13, 1297-1308[Abstract/Free FullText] Zhang, H., Zhang, R., Luo, Y., D'Alessio, A., Pober, J. 

Phrase: "13,"

Phrase: "1297-1308"

Phrase: "[Abstract/Free FullText"

Phrase: "] Zhang,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zhang,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Luo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0337841:Luo [Population Group]

Phrase: "Y.,"

Phrase: "D'"

Phrase: "Alessio,"

Phrase: "A.,"

Phrase: "Pober,"

Phrase: "J."
Processing 00000000.tx.358: S., and Min, W. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0702093:/min [Temporal Concept]

Phrase: "W."
Processing 00000000.tx.359: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.360: Biol. 

Phrase: "Biol."
Processing 00000000.tx.361: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.362: 279, 44955-44965[Abstract/Free FullText] Goossens, V., Grooten, J., De Vos, K., and Fiers, W. 

Phrase: "279,"

Phrase: "44955-44965"

Phrase: "[Abstract/Free FullText"

Phrase: "] Goossens,"

Phrase: "V.,"

Phrase: "Grooten,"

Phrase: "J.,"

Phrase: "De Vos,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Fiers,"

Phrase: "W."
Processing 00000000.tx.363: (1995) Proc. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.364: Natl. 

Phrase: "Natl."
Processing 00000000.tx.365: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.366: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.367: U. 

Phrase: "U."
Processing 00000000.tx.368: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.369: A. 

Phrase: "A."
Processing 00000000.tx.370: 92, 8115-8119[Abstract/Free FullText] Lin, Y., Choksi, S., Shen, H. 

Phrase: "92,"

Phrase: "8115-8119"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Y.,"

Phrase: "Choksi,"

Phrase: "S."

Phrase: ","

Phrase: "Shen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.371: M., Yang, Q. 

Phrase: "M."

Phrase: ","

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "Q."
Processing 00000000.tx.372: F., Hur, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Hur,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414371:HuR [Gene or Genome]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.373: M., Kim, Y. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "Y."
Processing 00000000.tx.374: S., Tran, J. 

Phrase: "S."

Phrase: ","

Phrase: "Tran,"

Phrase: "J."
Processing 00000000.tx.375: H., Nedospasov, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nedospasov,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.376: A., and Liu, Z. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Liu,"

Phrase: "Z."
Processing 00000000.tx.377: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.378: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.379: Biol. 

Phrase: "Biol."
Processing 00000000.tx.380: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.381: 279, 10822-10828[Abstract/Free FullText] Bradley, J. 

Phrase: "279,"

Phrase: "10822-10828"

Phrase: "[Abstract/Free FullText"

Phrase: "] Bradley,"

Phrase: "J."
Processing 00000000.tx.382: R., and Pober, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Pober,"

Phrase: "J."
Processing 00000000.tx.383: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.384: (2001) Oncogene 20, 6482-6491[CrossRef][Medline] [OrderarticleviaInfotrieve] Chung, J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Oncogene 20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "6482-6491"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Chung,"

Phrase: "J."
Processing 00000000.tx.385: Y., Park, Y. 

Phrase: "Y.,"

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "Y."
Processing 00000000.tx.386: C., Ye, H., and Wu, H. 

Phrase: "C., Ye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043402:YE [Geographic Area]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.387: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.388: Cell Sci. 

Phrase: "Cell Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.389: 115, 679-688[Abstract/Free FullText] Inoue, J., Ishida, T., Tsukamoto, N., Kobayashi, N., Naito, A., Azuma, S., and Yamamoto, T. 

Phrase: "115,"

Phrase: "679-688"

Phrase: "[Abstract/Free FullText"

Phrase: "] Inoue,"

Phrase: "J.,"

Phrase: "Ishida,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tsukamoto,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kobayashi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Naito,"

Phrase: "A.,"

Phrase: "Azuma,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.390: (2000) Exp. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.391: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.392: 254, 14-24[CrossRef][Medline] [OrderarticleviaInfotrieve] Nakano, H., Oshima, H., Chung, W., Williams-Abbott, L., Ware, C. 

Phrase: "254,"

Phrase: "14-24"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Nakano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Oshima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chung,"

Phrase: "W.,"

Phrase: "Williams-Abbott,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331761:Abbott [Health Care Related Organization]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ware,"

Phrase: "C."
Processing 00000000.tx.393: F., Yagita, H., and Okumura, K. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Yagita,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Okumura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.394: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.395: Biol. 

Phrase: "Biol."
Processing 00000000.tx.396: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.397: 271, 14661-14664[Abstract/Free FullText] Akiba, H., Nakano, H., Nishinaka, S., Shindo, M., Kobata, T., Atsuta, M., Morimoto, C., Ware, C. 

Phrase: "271,"

Phrase: "14661-14664"

Phrase: "[Abstract/Free FullText"

Phrase: "] Akiba,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nakano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nishinaka,"

Phrase: "S."

Phrase: ","

Phrase: "Shindo,"

Phrase: "M."

Phrase: ","

Phrase: "Kobata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Atsuta,"

Phrase: "M."

Phrase: ","

Phrase: "Morimoto,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ware,"

Phrase: "C."
Processing 00000000.tx.398: F., Malinin, N. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Malinin,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.399: L., Wallach, D., Yagita, H., and Okumura, K. 

Phrase: "L., Wallach,"

Phrase: "D."

Phrase: ","

Phrase: "Yagita,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Okumura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.400: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.401: Biol. 

Phrase: "Biol."
Processing 00000000.tx.402: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.403: 273, 13353-13358[Abstract/Free FullText] Ishida, T. 

Phrase: "273,"

Phrase: "13353-13358"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ishida,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.404: K., Tojo, T., Aoki, T., Kobayashi, N., Ohishi, T., Watanabe, T., Yamamoto, T., and Inoue, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tojo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Aoki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kobayashi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ohishi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Watanabe,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Inoue,"

Phrase: "J."
Processing 00000000.tx.405: (1996) Proc. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.406: Natl. 

Phrase: "Natl."
Processing 00000000.tx.407: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.408: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.409: U. 

Phrase: "U."
Processing 00000000.tx.410: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.411: A. 

Phrase: "A."
Processing 00000000.tx.412: 93, 9437-9442[Abstract/Free FullText] Nakano, H., Sakon, S., Koseki, H., Takemori, T., Tada, K., Matsumoto, M., Munechika, E., Sakai, T., Shirasawa, T., Akiba, H., Kobata, T., Santee, S. 

Phrase: "93,"

Phrase: "9437-9442"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakano,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sakon,"

Phrase: "S."

Phrase: ","

Phrase: "Koseki,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takemori,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Tada,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Matsumoto,"

Phrase: "M."

Phrase: ","

Phrase: "Munechika,"

Phrase: "E.,"

Phrase: "Sakai,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Shirasawa,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Akiba,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kobata,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Santee,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0574595:Santee [Language]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.413: M., Ware, C. 

Phrase: "M."

Phrase: ","

Phrase: "Ware,"

Phrase: "C."
Processing 00000000.tx.414: F., Rennert, P. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rennert,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.415: D., Taniguchi, M., Yagita, H., and Okumura, K. 

Phrase: "D."

Phrase: ","

Phrase: "Taniguchi,"

Phrase: "M."

Phrase: ","

Phrase: "Yagita,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Okumura,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.416: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.417: Natl. 

Phrase: "Natl."
Processing 00000000.tx.418: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.419: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.420: U. 

Phrase: "U."
Processing 00000000.tx.421: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.422: A. 

Phrase: "A."
Processing 00000000.tx.423: 96, 9803-9808[Abstract/Free FullText] Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., and Inoue, J. 

Phrase: "96,"

Phrase: "9803-9808"

Phrase: "[Abstract/Free FullText"

Phrase: "] Naito,"

Phrase: "A.,"

Phrase: "Azuma,"

Phrase: "S."

Phrase: ","

Phrase: "Tanaka,"

Phrase: "S."

Phrase: ","

Phrase: "Miyazaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Takaki,"

Phrase: "S."

Phrase: ","

Phrase: "Takatsu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nakao,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Nakamura,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Katsuki,"

Phrase: "M."

Phrase: ","

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Inoue,"

Phrase: "J."
Processing 00000000.tx.424: (1999) Genes Cells 4, 353-362[Abstract/Free FullText] Gohda, J., Matsumura, T., and Inoue, J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genes Cells 4,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0007634:Cells [Cell]
   827   C0017337:Genes [Gene or Genome]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "353-362"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gohda,"

Phrase: "J.,"

Phrase: "Matsumura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Inoue,"

Phrase: "J."
Processing 00000000.tx.425: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.426: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.427: 173, 2913-2917[Abstract/Free FullText] Ishida, T., Mizushima, S., Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., Yamamoto, T., and Inoue, J. 

Phrase: "173,"

Phrase: "2913-2917"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ishida,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mizushima,"

Phrase: "S."

Phrase: ","

Phrase: "Azuma,"

Phrase: "S."

Phrase: ","

Phrase: "Kobayashi,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Tojo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Suzuki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0998924:suzuki [Fish]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Aizawa,"

Phrase: "S."

Phrase: ","

Phrase: "Watanabe,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mosialos,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kieff,"

Phrase: "E.,"

Phrase: "Yamamoto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450955:Yamamoto [Body Location or Region]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Inoue,"

Phrase: "J."
Processing 00000000.tx.428: (1996) J. 

Phrase: "(1996"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.429: Biol. 

Phrase: "Biol."
Processing 00000000.tx.430: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.431: 271, 28745-28748[Abstract/Free FullText] Wong, B. 

Phrase: "271,"

Phrase: "28745-28748"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wong,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.432: R., Besser, D., Kim, N., Arron, J. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Besser,"

Phrase: "D."

Phrase: ","

Phrase: "Kim,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Arron,"

Phrase: "J."
Processing 00000000.tx.433: R., Vologodskaia, M., Hanafusa, H., and Choi, Y. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Vologodskaia,"

Phrase: "M."

Phrase: ","

Phrase: "Hanafusa,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Choi,"

Phrase: "Y."
Processing 00000000.tx.434: (1999) Mol. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.435: Cell 4, 1041-1049[CrossRef][Medline] [OrderarticleviaInfotrieve] Lomaga, M. 

Phrase: "Cell 4,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1041-1049"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lomaga,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.436: A., Yeh, W. 

Phrase: "A.,"

Phrase: "Yeh,"

Phrase: "W."
Processing 00000000.tx.437: C., Sarosi, I., Duncan, G. 

Phrase: "C., Sarosi,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Duncan,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.438: S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., van der Heiden, A., Itie, A., Wakeham, A., Khoo, W., Sasaki, T., Cao, Z., Penninger, J. 

Phrase: "S."

Phrase: ","

Phrase: "Furlonger,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "A.,"

Phrase: "Morony,"

Phrase: "S."

Phrase: ","

Phrase: "Capparelli,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Van,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0557775:Van [Manufactured Object]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kaufman,"

Phrase: "S."

Phrase: ","

Phrase: "van der Heiden,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "A.,"

Phrase: "Itie,"

Phrase: "A.,"

Phrase: "Wakeham,"

Phrase: "A.,"

Phrase: "Khoo,"

Phrase: "W.,"

Phrase: "Sasaki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cao,"

Phrase: "Z.,"

Phrase: "Penninger,"

Phrase: "J."
Processing 00000000.tx.439: M., Paige, C. 

Phrase: "M."

Phrase: ","

Phrase: "Paige,"

Phrase: "C."
Processing 00000000.tx.440: J., Lacey, D. 

Phrase: "J.,"

Phrase: "Lacey,"

Phrase: "D."
Processing 00000000.tx.441: L., Dunstan, C. 

Phrase: "L., Dunstan,"

Phrase: "C."
Processing 00000000.tx.442: R., Boyle, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Boyle,"

Phrase: "W."
Processing 00000000.tx.443: J., Goeddel, D. 

Phrase: "J.,"

Phrase: "Goeddel,"

Phrase: "D."
Processing 00000000.tx.444: V., and Mak, T. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Mak,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416988:MAK [Gene or Genome]
  1000   C1538267:MAK [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.445: W. 

Phrase: "W."
Processing 00000000.tx.446: (1999) Genes Dev. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Genes Dev."
Processing 00000000.tx.447: 13, 1015-1024[Abstract/Free FullText] Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J., Cao, Z., and Matsumoto, K. 

Phrase: "13,"

Phrase: "1015-1024"

Phrase: "[Abstract/Free FullText"

Phrase: "] Ninomiya-Tsuji,"

Phrase: "J.,"

Phrase: "Kishimoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hiyama,"

Phrase: "A.,"

Phrase: "Inoue,"

Phrase: "J.,"

Phrase: "Cao,"

Phrase: "Z.,"

Phrase: "and"

Phrase: "Matsumoto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.448: (1999) Nature 398, 252-256[CrossRef][Medline] [OrderarticleviaInfotrieve] Huang, Q., Yang, J., Lin, Y., Walker, C., Cheng, J., Liu, Z. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "252-256"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Huang,"

Phrase: "Q.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "J.,"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Y.,"

Phrase: "Walker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043016:Walker [Medical Device]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Cheng,"

Phrase: "J.,"

Phrase: "Liu,"

Phrase: "Z."
Processing 00000000.tx.449: G., and Su, B. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Su,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705534:SU [Idea or Concept]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.450: (2004) Nat. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.451: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.452: 5, 98-103[CrossRef][Medline] [OrderarticleviaInfotrieve] Matsuzawa, A., Saegusa, K., Noguchi, T., Sadamitsu, C., Nishitoh, H., Nagai, S., Koyasu, S., Matsumoto, K., Takeda, K., and Ichijo, H. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "98-103"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Matsuzawa,"

Phrase: "A.,"

Phrase: "Saegusa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Noguchi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Sadamitsu,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Nishitoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nagai,"

Phrase: "S."

Phrase: ","

Phrase: "Koyasu,"

Phrase: "S."

Phrase: ","

Phrase: "Matsumoto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Takeda,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Ichijo,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.453: (2005) Nat. 

Phrase: "(2005"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.454: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.455: 6, 587-592[CrossRef][Medline] [OrderarticleviaInfotrieve] Zou, H., Li, Y., Liu, X., and Wang, X. 

Phrase: "6,"

Phrase: "587-592"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zou,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Y.,"

Phrase: "Liu,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Wang,"

Phrase: "X."
Processing 00000000.tx.456: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.457: Biol. 

Phrase: "Biol."
Processing 00000000.tx.458: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.459: 274, 11549-11556[Abstract/Free FullText] Shen, H. 

Phrase: "274,"

Phrase: "11549-11556"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shen,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.460: M., Lin, Y., Choksi, S., Tran, J., Jin, T., Chang, L., Karin, M., Zhang, J., and Liu, Z. 

Phrase: "M."

Phrase: ","

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "Y.,"

Phrase: "Choksi,"

Phrase: "S."

Phrase: ","

Phrase: "Tran,"

Phrase: "J.,"

Phrase: "Jin,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Chang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Karin,"

Phrase: "M."

Phrase: ","

Phrase: "Zhang,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Liu,"

Phrase: "Z."
Processing 00000000.tx.461: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.462: (2004) Mol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.463: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.464: Biol. 

Phrase: "Biol."
Processing 00000000.tx.465: 24, 5914-5922[Abstract/Free FullText] Yeh, W. 

Phrase: "24,"

Phrase: "5914-5922"

Phrase: "[Abstract/Free FullText"

Phrase: "] Yeh,"

Phrase: "W."
Processing 00000000.tx.466: C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. 

Phrase: "C., Shahinian,"

Phrase: "A.,"

Phrase: "Speiser,"

Phrase: "D."

Phrase: ","

Phrase: "Kraunus,"

Phrase: "J.,"

Phrase: "Billia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1060274:Billia [Plant]

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wakeham,"

Phrase: "A.,"

Phrase: "de la Pompa,"

Phrase: "J."
Processing 00000000.tx.467: L., Ferrick, D., Hum, B., Iscove, N., Ohashi, P., Rothe, M., Goeddel, D. 

Phrase: "L., Ferrick,"

Phrase: "D."

Phrase: ","

Phrase: "Hum,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Iscove,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Ohashi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rothe,"

Phrase: "M."

Phrase: ","

Phrase: "Goeddel,"

Phrase: "D."
Processing 00000000.tx.468: V., and Mak, T. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Mak,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1416988:MAK [Gene or Genome]
  1000   C1538267:MAK [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.469: W. 

Phrase: "W."
Processing 00000000.tx.470: (1997) Immunity 7, 715-725[CrossRef][Medline] [OrderarticleviaInfotrieve] DiDonato, J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Immunity 7,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: "715-725"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] DiDonato,"

Phrase: "J."
Processing 00000000.tx.471: A., Hayakawa, M., Rothwarf, D. 

Phrase: "A.,"

Phrase: "Hayakawa,"

Phrase: "M."

Phrase: ","

Phrase: "Rothwarf,"

Phrase: "D."
Processing 00000000.tx.472: M., Zandi, E., and Karin, M. 

Phrase: "M."

Phrase: ","

Phrase: "Zandi,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.473: (1997) Nature 388, 548-554[CrossRef][Medline] [OrderarticleviaInfotrieve] Rothwarf, D. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "548-554"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Rothwarf,"

Phrase: "D."
Processing 00000000.tx.474: M., Zandi, E., Natoli, G., and Karin, M. 

Phrase: "M."

Phrase: ","

Phrase: "Zandi,"

Phrase: "E.,"

Phrase: "Natoli,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.475: (1998) Nature 395, 297-300[CrossRef][Medline] [OrderarticleviaInfotrieve] Zandi, E., Rothwarf, D. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nature 395,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "297-300"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Zandi,"

Phrase: "E.,"

Phrase: "Rothwarf,"

Phrase: "D."
Processing 00000000.tx.476: M., Delhase, M., Hayakawa, M., and Karin, M. 

Phrase: "M."

Phrase: ","

Phrase: "Delhase,"

Phrase: "M."

Phrase: ","

Phrase: "Hayakawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Karin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.477: (1997) Cell 91, 243-252[CrossRef][Medline] [OrderarticleviaInfotrieve] Karin, M., and Ben-Neriah, Y. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Cell 91,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "243-252"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Karin,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ben-Neriah,"

Phrase: "Y."
Processing 00000000.tx.478: (2000) Annu. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.479: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.480: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.481: 18, 621-663[CrossRef][Medline] [OrderarticleviaInfotrieve] Tanaka, M., Fuentes, M. 

Phrase: "18,"

Phrase: "621-663"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tanaka,"

Phrase: "M."

Phrase: ","

Phrase: "Fuentes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.482: E., Yamaguchi, K., Durnin, M. 

Phrase: "E.,"

Phrase: "Yamaguchi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Durnin,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.483: H., Dalrymple, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dalrymple,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.484: A., Hardy, K. 

Phrase: "A.,"

Phrase: "Hardy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.485: L., and Goeddel, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Goeddel,"

Phrase: "D."
Processing 00000000.tx.486: V. 

Phrase: "V."
Processing 00000000.tx.487: (1999) Immunity 10, 421-429[CrossRef][Medline] [OrderarticleviaInfotrieve] Karin, M., and Lin, A. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Immunity 10,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0020964:Immunity [Physiologic Function]
   789 E C0439662:Immune [Functional Concept]

Phrase: "421-429"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Karin,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "A."
Processing 00000000.tx.488: (2002) Nat. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.489: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.490: 3, 221-227[CrossRef][Medline] [OrderarticleviaInfotrieve] Acehan, D., Jiang, X., Morgan, D. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "221-227"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Acehan,"

Phrase: "D."

Phrase: ","

Phrase: "Jiang,"

Phrase: "X.,"

Phrase: "Morgan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582521:morgan [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.491: G., Heuser, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Heuser,"

Phrase: "J."
Processing 00000000.tx.492: E., Wang, X., and Akey, C. 

Phrase: "E.,"

Phrase: "Wang,"

Phrase: "X.,"

Phrase: "and"

Phrase: "Akey,"

Phrase: "C."
Processing 00000000.tx.493: W. 

Phrase: "W."
Processing 00000000.tx.494: (2002) Mol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.495: Cell 9, 423-432[CrossRef][Medline] [OrderarticleviaInfotrieve] Tschopp, J., Martinon, F., and Burns, K. 

Phrase: "Cell 9,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "423-432"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tschopp,"

Phrase: "J.,"

Phrase: "Martinon,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Burns,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006434:Burns [Injury or Poisoning]
   966 E C1550619:Burn [Substance]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.496: (2003) Nat. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.497: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.498: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.499: Cell. 

Phrase: "Cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.500: Biol. 

Phrase: "Biol."
Processing 00000000.tx.501: 4, 95-104[CrossRef][Medline] [OrderarticleviaInfotrieve] Martinon, F., Burns, K., and Tschopp, J. 

Phrase: "4,"

Phrase: "95-104"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Martinon,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Burns,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0006434:Burns [Injury or Poisoning]
   966 E C1550619:Burn [Substance]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Tschopp,"

Phrase: "J."
Processing 00000000.tx.502: (2002) Mol. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.503: Cell 10, 417-426[CrossRef][Medline] [OrderarticleviaInfotrieve] Martinon, F., and Tschopp, J. 

Phrase: "Cell 10,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "417-426"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Martinon,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Tschopp,"

Phrase: "J."
Processing 00000000.tx.504: (2004) Cell 117, 561-574[CrossRef][Medline] [OrderarticleviaInfotrieve] Pullen, S. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Cell 117,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "561-574"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Pullen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.505: S., Labadia, M. 

Phrase: "S."

Phrase: ","

Phrase: "Labadia,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.506: E., Ingraham, R. 

Phrase: "E.,"

Phrase: "Ingraham,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.507: H., McWhirter, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "McWhirter,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.508: M., Everdeen, D. 

Phrase: "M."

Phrase: ","

Phrase: "Everdeen,"

Phrase: "D."
Processing 00000000.tx.509: S., Alber, T., Crute, J. 

Phrase: "S."

Phrase: ","

Phrase: "Alber,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Crute,"

Phrase: "J."
Processing 00000000.tx.510: J., and Kehry, M. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Kehry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.511: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.512: (1999) Biochemistry 38, 10168-10177[CrossRef][Medline] [OrderarticleviaInfotrieve] McWhirter, S. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochemistry 38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "10168-10177"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] McWhirter,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.513: M., Pullen, S. 

Phrase: "M."

Phrase: ","

Phrase: "Pullen,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.514: S., Holton, J. 

Phrase: "S."

Phrase: ","

Phrase: "Holton,"

Phrase: "J."
Processing 00000000.tx.515: M., Crute, J. 

Phrase: "M."

Phrase: ","

Phrase: "Crute,"

Phrase: "J."
Processing 00000000.tx.516: J., Kehry, M. 

Phrase: "J.,"

Phrase: "Kehry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.517: R., and Alber, T. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Alber,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.518: (1999) Proc. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.519: Natl. 

Phrase: "Natl."
Processing 00000000.tx.520: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.521: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.522: U. 

Phrase: "U."
Processing 00000000.tx.523: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.524: A. 

Phrase: "A."
Processing 00000000.tx.525: 96, 8408-8413[Abstract/Free FullText] Park, Y. 

Phrase: "96,"

Phrase: "8408-8413"

Phrase: "[Abstract/Free FullText"

Phrase: "] Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "Y."
Processing 00000000.tx.526: C., Burkitt, V., Villa, A. 

Phrase: "C., Burkitt,"

Phrase: "V.,"

Phrase: "Villa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1188484:Villa [Eukaryote]

Phrase: "A."
Processing 00000000.tx.527: R., Tong, L., and Wu, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Tong,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0183964:Tong [Medical Device]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.528: (1999) Nature 398, 533-538[CrossRef][Medline] [OrderarticleviaInfotrieve] Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., and Chen, Z. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Nature 398,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "533-538"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Spencer,"

Phrase: "E.,"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Braun,"

Phrase: "A.,"

Phrase: "You,"

Phrase: "J.,"

Phrase: "Slaughter,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pickart,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Z."
Processing 00000000.tx.529: J. 

Phrase: "J."
Processing 00000000.tx.530: (2000) Cell 103, 351-361[CrossRef][Medline] [OrderarticleviaInfotrieve] Sun, L., Deng, L., Ea, C. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Cell 103,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "351-361"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038817:Sun [Natural Phenomenon or Process]
  1000   C0376223:Sun [Geographic Area]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ea,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014963:EA [Organic Chemical,Pharmacologic Substance]
  1000   C1457900:EA [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.531: K., Xia, Z. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Xia,"

Phrase: "Z."
Processing 00000000.tx.532: P., and Chen, Z. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Z."
Processing 00000000.tx.533: J. 

Phrase: "J."
Processing 00000000.tx.534: (2004) Mol. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.535: Cell 14, 289-301[CrossRef][Medline] [OrderarticleviaInfotrieve] Wang, C., Deng, L., Hong, M., Akkaraju, G. 

Phrase: "Cell 14,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "289-301"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Wang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Deng,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1549988:DEng [Intellectual Product]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hong,"

Phrase: "M."

Phrase: ","

Phrase: "Akkaraju,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.536: R., Inoue, J., and Chen, Z. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Inoue,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Z."
Processing 00000000.tx.537: J. 

Phrase: "J."
Processing 00000000.tx.538: (2001) Nature 412, 346-351[CrossRef][Medline] [OrderarticleviaInfotrieve] Habelhah, H., Takahashi, S., Cho, S. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Nature 412,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "346-351"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Habelhah,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "S."

Phrase: ","

Phrase: "Cho,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.539: G., Kadoya, T., Watanabe, T., and Ronai, Z. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Kadoya,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Watanabe,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Ronai,"

Phrase: "Z."
Processing 00000000.tx.540: (2004) EMBO J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "EMBO J."
Processing 00000000.tx.541: 23, 322-332[Abstract/Free FullText] Shi, C. 

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "322-332"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shi,"

Phrase: "C."
Processing 00000000.tx.542: S., and Kehrl, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kehrl,"

Phrase: "J."
Processing 00000000.tx.543: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.544: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.545: Biol. 

Phrase: "Biol."
Processing 00000000.tx.546: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.547: 278, 15429-15434[Abstract/Free FullText] Lee, T. 

Phrase: "278,"

Phrase: "15429-15434"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lee,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.548: H., Shank, J., Cusson, N., and Kelliher, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Shank,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444675:Shank [Body Location or Region]
  1000   C1422551:SHANK [Gene or Genome]

Phrase: "J.,"

Phrase: "Cusson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Kelliher,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.549: A. 

Phrase: "A."
Processing 00000000.tx.550: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.551: Biol. 

Phrase: "Biol."
Processing 00000000.tx.552: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.553: 279, 33185-33191[Abstract/Free FullText] This Article Abstract Full Text (PDF) All Versions of this Article: 280/44/37033 most recent M506771200v1 Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Permissions Google Scholar Articles by Noguchi, T. 

Phrase: "279,"

Phrase: "33185-33191"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "This Article Abstract Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C1527021:Text [Intellectual Product]
   812   C1554111:Text [Idea or Concept]
   812   C1705606:Text [Intellectual Product]
   812   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "280/44/37033 most recent M506771200v1 Purchase Article View Shopping Cart"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   801   C0441061:Shopping cart [Manufactured Object]
   788   C0179636:Cart [Manufactured Object]
   788   C1824528:CART [Gene or Genome]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Citation Map Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0557854:Services [Occupational Activity]
   793 E C2825316:Service [Manufactured Object]
   793 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal Download"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0162443:Journal [Intellectual Product,Manufactured Object]
   744   C0205314:New [Temporal Concept]
   711   C0033213:Issue [Finding]
   711   C1706387:Issue [Intellectual Product]

Phrase: "to citation manager Copyright Permissions Google Scholar Articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C1706852:Article [Intellectual Product]

Phrase: "by Noguchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.554: Articles by Ichijo, H. 

Phrase: "Articles by Ichijo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.555: PubMed PubMed Citation Articles by Noguchi, T. 

Phrase: "PubMed PubMed Citation Articles by Noguchi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.556: Articles by Ichijo, H. 

Phrase: "Articles by Ichijo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.557: HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS All ASBMB Journals Molecular and Cellular Proteomics Journal of Lipid Research Biochemistry and Molecular Biology Education Copyright  2005 by the American Society for Biochemistry and Molecular Biology.

Phrase: "HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0039224:Table [Manufactured Object]
   742   C1706073:Table [Medical Device]
   742   C1706074:Table [Intellectual Product]

Phrase: "All ASBMB Journals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0162443:journals [Intellectual Product,Manufactured Object]

Phrase: "Molecular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521991:Molecular [Qualitative Concept]
   928 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cellular Proteomics Journal of Lipid Research Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Molecular Biology Education Copyright  2005 by the American Society"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   742   C0005532:Biology [Biomedical Occupation or Discipline]
   742   C0009993:Copyright [Intellectual Product]
   742   C0013621:Education [Educational Activity]
   742   C0013622:education [Classification]
   742   C0013658:Education, NOS [Finding]
   742   C0037455:society [Organization]
   742   C0039401:Education [Educational Activity]
   742   C0596070:American [Population Group]
   742   C1521991:Molecular [Qualitative Concept]
   742   C1552856:copyright [Idea or Concept]

Phrase: "for Biochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "and"

Phrase: "Molecular Biology."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C0567416:Molecule [Substance]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

